Regenerative Medicine (RM), the use of advanced technologies to regenerate or replace human cells, tissues, or organs, has become such an important field, holding such recognized potential that there is a major effort to help the industry accelerate the development and commercialization of its products. To that end, a government funded not-for-profit organization was formed in Canada in June of 2011 to address and reduce the bottlenecks in the product pipelines of member companies.
The Centre for Commercialization of Regenerative Medicine (CCRM), based in Canada, has brought together an international collection of companies, including VistaGen Therapeutics, representing the key sectors of the RM industry: therapeutics, devices, reagents, and cells-as-tools. CCRM has built three core development platforms:
• Reprogramming
• Cell Manufacturing
• Biomaterials and Tissue Mimetics
Together with its research institution partners and resources, and the support of its 20 member companies, CCRM’s efforts are expected to benefit both Canada and the world in helping to promote the movement of these critical technologies from the laboratory to the marketplace. The Chair of CCRM’s Board, Greg Bonfiglio, summarized the opportunity: “CCRM is uniquely positioned to meet the needs of industry and academia. CCRM boasts scientific expertise and state-of-the-art resources in its development lab and this combination will benefit the regenerative medicine community that can capitalize on our ability to complete projects quickly and cost competitively.”
VistaGen uses advanced stem cell technology to create viable human heart cells, or other cells, that can be used for highly accurate early-stage drug testing, allowing drug developers to better avoid going to all of the cost and effort of bringing a drug to market only to have it removed due to heart toxicity issues. It addresses a major problem for the drug industry, where the cost of new drug development can easily top $1 billion and existing early stage testing methods are insufficient to verify safety before significant resources are employed.
For additional information, visit the company’s website at www.VistaGen.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Friday, March 30, 2012
AdCare Health Systems, Inc. (ADK) Closes Previously Announced Public Offering of Common Stock
Today, AdCare Health Systems announced the completion of its previously announced firm commitment underwritten offering of 1,100,000 shares of AdCare’s common stock at a price per share to the public of $3.75. The net proceeds from the offering, after underwriting discounts and commissions and other offering expenses, were reported at approximately $3.7 million.
According to today’s press release, AdCare plans to use the net proceeds from the offering for working capital and other general corporate purposes. Noble Financial Capital Markets acted as sole underwriter for the offering, and all conditions to the closing of the offering were satisfied.
The shares of common stock were offered pursuant to AdCare’s existing effective shelf registration statement that was previously filed with the Securities and Exchange Commission and declared effective last year. A final prospectus supplement relating to the offering was filed with the Securities and Exchange Commission three days ago. Copies of the final prospectus supplement and the accompanying prospectus may be obtained from Noble Financial Capital Markets.
AdCare Health Systems is an expanding national leader in the development, ownership, and management of assisted living facilities, skilled nursing, and retirement communities. The company’s 3,600 employees provide high-quality care for patients and residents residing in the 44 facilities that it operates with a total of approximately 3,900 beds/units in service.
Since inception, AdCare’s mission has been to provide the highest quality healthcare services to the elderly. With nine straight years of record revenue growth, the company has proven its ability to deliver high-quality care and strong operational efficiency. AdCare is well positioned to continue growing rapidly, both organically and via acquisitions, as industry trends and burgeoning opportunities across the U.S. increase the demand for long-term care.
To learn more about AdCare Health, visit its website at: www.AdCareHealth.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
According to today’s press release, AdCare plans to use the net proceeds from the offering for working capital and other general corporate purposes. Noble Financial Capital Markets acted as sole underwriter for the offering, and all conditions to the closing of the offering were satisfied.
The shares of common stock were offered pursuant to AdCare’s existing effective shelf registration statement that was previously filed with the Securities and Exchange Commission and declared effective last year. A final prospectus supplement relating to the offering was filed with the Securities and Exchange Commission three days ago. Copies of the final prospectus supplement and the accompanying prospectus may be obtained from Noble Financial Capital Markets.
AdCare Health Systems is an expanding national leader in the development, ownership, and management of assisted living facilities, skilled nursing, and retirement communities. The company’s 3,600 employees provide high-quality care for patients and residents residing in the 44 facilities that it operates with a total of approximately 3,900 beds/units in service.
Since inception, AdCare’s mission has been to provide the highest quality healthcare services to the elderly. With nine straight years of record revenue growth, the company has proven its ability to deliver high-quality care and strong operational efficiency. AdCare is well positioned to continue growing rapidly, both organically and via acquisitions, as industry trends and burgeoning opportunities across the U.S. increase the demand for long-term care.
To learn more about AdCare Health, visit its website at: www.AdCareHealth.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
It’s Hard to Overlook Longhai Steel, Inc. (LGHS)
Scrolling through another batch of earnings reports from big board companies in the steel business once again showcases the out-of-sync valuation of Longhai Steel and its industry peers.
Olympic Steel (NASDAQ: ZEUS) reported Q4 2011 net sales totaled $319.9 million, the highest ever for its fourth quarter, an increase of 48.7% from the $215.2 million reported for the year-ago period. Fourth quarter 2011 net income totaled $0.6 million, or $0.05 per diluted share, compared to a net loss of $1.6 million, or $0.15 per diluted share, in last year’s fourth quarter. Net sales for the year totaled $1.26 billion in 2011, a new record, increasing 56.7% from $805 million in 2010. For 2011, net income increased by $22.9 million to $25.0 million, or $2.28 per diluted share, compared to net income of $2.1 million, or $0.20 per diluted share, for 2010. Shares are trading around $24 each with a market cap of approximately $260 million.
China Gerui Advanced Materials Group (NASDAQ:CHOP) reported 2011 Q3 revenue of $101.1 million as compared to $61.9 million in the same quarter of 2010. Gross profit for the quarter was reported at $32.1 million; up from $18.6 million in the 2011 quarter. Operating income increased to $28.7 million from $16.5 million. Notably, the company was recently upgraded to NASDAQ Global Select. China Gerui has no long-term debt, but more than $216 million in short-term debt. Shares are trading at $3.57 with a market cap of approximately $210 million.
Schnitzer Steel Industries (NASDAQ:SCHN) said that it expects fully diluted earnings per share for the second quarter to be approximately $0.28 – $0.35. The company will report its earnings next week. Shares are trading at around $40 with a market cap of approximately $1.1 billion.
For its third quarter ended Feb. 29, 2012, Worthington Industries (NYSE: WOR) reported a profit of $25.9 million, or 37 cents a share, down from $26.3 million, or 35 cents a share, a year earlier on a 7.3% gain in revenues. Revenue at Worthington’s steel processing business, its biggest by sales, rose 22% to $367.3 million. Shares are currently trading at $19.14 each with a market cap of approximately $1.33 billion.
The unsung hero in this business looks to be Longhai Steel (OTCBB: LGHS), a producer of high-quality steel wire products in the People’s Republic of China. Today, the company announced its financial results for the year ended December 31, 2011, which included steel wire sales revenue of $608 million compared with $475 million for 2010, an increase of $133 million, or 28 percent. 2011 gross profit rang-in at $18.7 million compared to gross profit of $18.6 million for 2010. 2011 net income was $11.2 million, or $1.12 per fully diluted share, compared with net income of $11.3 million for 2010.
As of December 31, 2011, shareholder’s equity equaled $57.5 million, or $5.72 per fully diluted share. Longhai has no long-term debt. Shares are trading at $1.60 each with a market cap of $14.8 million.
Shares have risen in value for LGHS recently, but this company still seems to have tremendous upside potential to get on par in valuation with others in the industry. The new plant getting fully online could potentially send annual sales near the $1 billion mark.
Mr. Steven Ross, Executive Vice President of Longhai, said in today’s release, “We are pleased to report record sales for 2011, largely driven by the opening of our new production facility in the fourth quarter of 2011. As the newly-opened steel wire facility continues to ramp output, we expect to see continued year-over-year improvements in operating results throughout 2012. During the first quarter of 2012 we also reconstituted our Board of Directors and transitioned to a new auditing firm, Marcum Bernstein & Pinchuk, LLP, both significant steps toward our goal of moving to a senior exchange.”
Ross continued, “Once fully ramped, the new facility will increase our overall capacity by approximately 60%, and have the capability to produce such high margin products as alloy steel, cold forging steel and welding rods. Over the next two quarters we expect to begin utilizing higher quality steel billets, which will enable us to produce higher quality and higher margin products for additional markets beyond construction and infrastructure.”
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Olympic Steel (NASDAQ: ZEUS) reported Q4 2011 net sales totaled $319.9 million, the highest ever for its fourth quarter, an increase of 48.7% from the $215.2 million reported for the year-ago period. Fourth quarter 2011 net income totaled $0.6 million, or $0.05 per diluted share, compared to a net loss of $1.6 million, or $0.15 per diluted share, in last year’s fourth quarter. Net sales for the year totaled $1.26 billion in 2011, a new record, increasing 56.7% from $805 million in 2010. For 2011, net income increased by $22.9 million to $25.0 million, or $2.28 per diluted share, compared to net income of $2.1 million, or $0.20 per diluted share, for 2010. Shares are trading around $24 each with a market cap of approximately $260 million.
China Gerui Advanced Materials Group (NASDAQ:CHOP) reported 2011 Q3 revenue of $101.1 million as compared to $61.9 million in the same quarter of 2010. Gross profit for the quarter was reported at $32.1 million; up from $18.6 million in the 2011 quarter. Operating income increased to $28.7 million from $16.5 million. Notably, the company was recently upgraded to NASDAQ Global Select. China Gerui has no long-term debt, but more than $216 million in short-term debt. Shares are trading at $3.57 with a market cap of approximately $210 million.
Schnitzer Steel Industries (NASDAQ:SCHN) said that it expects fully diluted earnings per share for the second quarter to be approximately $0.28 – $0.35. The company will report its earnings next week. Shares are trading at around $40 with a market cap of approximately $1.1 billion.
For its third quarter ended Feb. 29, 2012, Worthington Industries (NYSE: WOR) reported a profit of $25.9 million, or 37 cents a share, down from $26.3 million, or 35 cents a share, a year earlier on a 7.3% gain in revenues. Revenue at Worthington’s steel processing business, its biggest by sales, rose 22% to $367.3 million. Shares are currently trading at $19.14 each with a market cap of approximately $1.33 billion.
The unsung hero in this business looks to be Longhai Steel (OTCBB: LGHS), a producer of high-quality steel wire products in the People’s Republic of China. Today, the company announced its financial results for the year ended December 31, 2011, which included steel wire sales revenue of $608 million compared with $475 million for 2010, an increase of $133 million, or 28 percent. 2011 gross profit rang-in at $18.7 million compared to gross profit of $18.6 million for 2010. 2011 net income was $11.2 million, or $1.12 per fully diluted share, compared with net income of $11.3 million for 2010.
As of December 31, 2011, shareholder’s equity equaled $57.5 million, or $5.72 per fully diluted share. Longhai has no long-term debt. Shares are trading at $1.60 each with a market cap of $14.8 million.
Shares have risen in value for LGHS recently, but this company still seems to have tremendous upside potential to get on par in valuation with others in the industry. The new plant getting fully online could potentially send annual sales near the $1 billion mark.
Mr. Steven Ross, Executive Vice President of Longhai, said in today’s release, “We are pleased to report record sales for 2011, largely driven by the opening of our new production facility in the fourth quarter of 2011. As the newly-opened steel wire facility continues to ramp output, we expect to see continued year-over-year improvements in operating results throughout 2012. During the first quarter of 2012 we also reconstituted our Board of Directors and transitioned to a new auditing firm, Marcum Bernstein & Pinchuk, LLP, both significant steps toward our goal of moving to a senior exchange.”
Ross continued, “Once fully ramped, the new facility will increase our overall capacity by approximately 60%, and have the capability to produce such high margin products as alloy steel, cold forging steel and welding rods. Over the next two quarters we expect to begin utilizing higher quality steel billets, which will enable us to produce higher quality and higher margin products for additional markets beyond construction and infrastructure.”
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
China Housing & Land Development, Inc. (CHLN) Reports Q4 FY11 Financials, Shows Strong Sales and Continued Growth Despite Government Policies
Today, China Housing & Land Development, a real estate firm based in Xi’an, the capital city of Shaanxi province, announced Q4 FY11 financials today, offering further evidence that the company is a true leader in the Chinese real estate space:
• Total Revenue – up 49.2% to $47.9M from Q3 FY11, and up 32.8% compared to Q4 FY10 (largely from the JunJing III, Puhua Phase I and Phase II projects)
• Operating Income – down 64.7% to $2.2M, or 4.5% of total revenue from Q3 FY11 (down $800k from Q4 FY10, due mainly to the decrease in gross margin)
• Gross Margin – down 15.3% to 14.4% from Q3 FY11, and down 8.3% from Q4 FY10 (largely due to increased general construction costs, combined with lower than projected contract sales for JunJing III project, as well as declining sales for parking spaces at Puhua Phase I, a typically 4-6% gross margin activity)
• Gross Profit – down 27.7% to $6.9M from Q3 FY11, and down 15.8% from Q4 FY10
• Net Income Attributable – $2.8M or $0.08/share (basic and diluted; or $2.5M excluding the $0.3M from derivative/warrant revaluations), compared to $4.4M in Q3 FY11 ($0.13/share basic and $0.12/share diluted)
• Total Contract Sales – up 45.4% to $44.6M from Q4 FY10
• Total Sales of Gross Floor Area (GFA) – up 80% to 480.4k sq. feet from the 267.9k sq. feet in Q3 FY11, and up 45.5% from Q4 FY10
• Average Residential Selling Price (ASP) – up 13% to roughly $1k (RMB 6,301), from $885 in Q3 FY11, and off slightly from the average price of $1058 in Q4 FY10 (due largely to the diminished Puhua Phase I parking lot sales)
• SG&A Expense as Percent of Total Revenue – down 2.1% to 7% from Q3 FY11, and down 3.4% from Q4 FY10
• Total Debt Outstanding – up 11% to $191.7M from Q3 FY11, and also up from the $143.9M of Q4 FY10
• Total Debt Less Cash – $64M compared to $57.6M in Q3 FY11, or $62.3M in Q4 FY10
• Net Debt Plus Shareholders’ Equity – down 16.4% to 33% from the 46.4% reported in Q3 FY11, and down 5% from Q4 FY10
Chairman of CHLN, Pingji Lu, underscored sequential improvements in GFA/ASP sales and continued growth across the three active Q4 projects (unJing III, Puhua Phase I and Puhua Phase II), but was quick to point out that restrictive government real estate policies continued to impact the business. Increases in overall footprint movement and price point were healthy, sequentially observable signs that the model is sound and continues to grow, despite a 12.8% drop in housing sales volume in Xi’an in Q4 (E-House China/Xi’an Bureau of Statistics).
The outlook for 2012 shows contract sales for Q1 off as much as 37.6%, with projected totals of $16.5-17.5M, and the same values for total recognized revenue (compared to $22.6M in 2011; contract sales estimates reported as compared to revenue, since they are not subject to percentage of completion alterations). Lu indicated that a lack of easing of government restrictions was the primary driver of slowed contract sales, adding that rising costs of labor and construction also played a key role.
Lu also pointed out that the company has the kind of flexibility to shift the timeline for development projects though, allowing for appropriate market conditions and timing to be utilized as a spring board. Good news for the Ankang project, the company’s latest development, which was added to the pipeline in Q4 and rests some 124 miles south of Xi’an. Ankang will be CHLN’s largest project outside of Xi’an thus far and the company wants to focus on middle income residential units (estimated GFA of 2,615,630 sq. feet) to accommodate China’s rapidly expanding middle class.
Lu was confident that the robust pipeline of ongoing developments, combined with the company’s ability to shift quickly and take advantage of opportune market conditions, would prove a fertile soil for overall profitability and the new Ankang project, which should start in Q2 this year (approximate build time of three years). Projected revenue generation from Ankang is $171.9M for the life of the project and represents the continued dedication of CHLN to both the real estate sector in China and the company’s shareholders, living up to its reputation as the first Chinese real estate firm to be traded on NASDAQ. CHLN has made a real name for itself as a top Tier II/III residential developer and occupies a considerably large market position in Western China, ideally positioned to capitalize off China’s growth.
A conference call by the company today which addressed the report is available through April 6, by dialing # 1-858-384-5517 ; passcode: 9714123.
For more information on China Housing & Land Development Inc., please visit the company’s website at: www.CHLDInc.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
• Total Revenue – up 49.2% to $47.9M from Q3 FY11, and up 32.8% compared to Q4 FY10 (largely from the JunJing III, Puhua Phase I and Phase II projects)
• Operating Income – down 64.7% to $2.2M, or 4.5% of total revenue from Q3 FY11 (down $800k from Q4 FY10, due mainly to the decrease in gross margin)
• Gross Margin – down 15.3% to 14.4% from Q3 FY11, and down 8.3% from Q4 FY10 (largely due to increased general construction costs, combined with lower than projected contract sales for JunJing III project, as well as declining sales for parking spaces at Puhua Phase I, a typically 4-6% gross margin activity)
• Gross Profit – down 27.7% to $6.9M from Q3 FY11, and down 15.8% from Q4 FY10
• Net Income Attributable – $2.8M or $0.08/share (basic and diluted; or $2.5M excluding the $0.3M from derivative/warrant revaluations), compared to $4.4M in Q3 FY11 ($0.13/share basic and $0.12/share diluted)
• Total Contract Sales – up 45.4% to $44.6M from Q4 FY10
• Total Sales of Gross Floor Area (GFA) – up 80% to 480.4k sq. feet from the 267.9k sq. feet in Q3 FY11, and up 45.5% from Q4 FY10
• Average Residential Selling Price (ASP) – up 13% to roughly $1k (RMB 6,301), from $885 in Q3 FY11, and off slightly from the average price of $1058 in Q4 FY10 (due largely to the diminished Puhua Phase I parking lot sales)
• SG&A Expense as Percent of Total Revenue – down 2.1% to 7% from Q3 FY11, and down 3.4% from Q4 FY10
• Total Debt Outstanding – up 11% to $191.7M from Q3 FY11, and also up from the $143.9M of Q4 FY10
• Total Debt Less Cash – $64M compared to $57.6M in Q3 FY11, or $62.3M in Q4 FY10
• Net Debt Plus Shareholders’ Equity – down 16.4% to 33% from the 46.4% reported in Q3 FY11, and down 5% from Q4 FY10
Chairman of CHLN, Pingji Lu, underscored sequential improvements in GFA/ASP sales and continued growth across the three active Q4 projects (unJing III, Puhua Phase I and Puhua Phase II), but was quick to point out that restrictive government real estate policies continued to impact the business. Increases in overall footprint movement and price point were healthy, sequentially observable signs that the model is sound and continues to grow, despite a 12.8% drop in housing sales volume in Xi’an in Q4 (E-House China/Xi’an Bureau of Statistics).
The outlook for 2012 shows contract sales for Q1 off as much as 37.6%, with projected totals of $16.5-17.5M, and the same values for total recognized revenue (compared to $22.6M in 2011; contract sales estimates reported as compared to revenue, since they are not subject to percentage of completion alterations). Lu indicated that a lack of easing of government restrictions was the primary driver of slowed contract sales, adding that rising costs of labor and construction also played a key role.
Lu also pointed out that the company has the kind of flexibility to shift the timeline for development projects though, allowing for appropriate market conditions and timing to be utilized as a spring board. Good news for the Ankang project, the company’s latest development, which was added to the pipeline in Q4 and rests some 124 miles south of Xi’an. Ankang will be CHLN’s largest project outside of Xi’an thus far and the company wants to focus on middle income residential units (estimated GFA of 2,615,630 sq. feet) to accommodate China’s rapidly expanding middle class.
Lu was confident that the robust pipeline of ongoing developments, combined with the company’s ability to shift quickly and take advantage of opportune market conditions, would prove a fertile soil for overall profitability and the new Ankang project, which should start in Q2 this year (approximate build time of three years). Projected revenue generation from Ankang is $171.9M for the life of the project and represents the continued dedication of CHLN to both the real estate sector in China and the company’s shareholders, living up to its reputation as the first Chinese real estate firm to be traded on NASDAQ. CHLN has made a real name for itself as a top Tier II/III residential developer and occupies a considerably large market position in Western China, ideally positioned to capitalize off China’s growth.
A conference call by the company today which addressed the report is available through April 6, by dialing # 1-858-384-5517 ; passcode: 9714123.
For more information on China Housing & Land Development Inc., please visit the company’s website at: www.CHLDInc.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
BioClinica, Inc. (BIOC) and Mirada Medical Partner for New Era of Molecular Image Analysis in Clinical Trials
BioClinica, a global provider of clinical trial management solutions, today announced a collaborative agreement with Mirada Medical, a leading provider of medical image analysis software, to integrate Miranda’s XD3 software solution into BioClinica’s existing imaging core lab technology. This partnership will allow BioClinica to further augment its PET capabilities and expertise for molecular imaging trials.
Mirada Medical’s XD3 software delivers specialized tools along with efficient workflows used for the quantification and tracking of findings for major modalities including PET, CT, MR, and MR/PET. BioClinica’s detailed evaluation of available molecular imaging solutions led to the selection of Mirada. Mirada offers not only cutting edge image analysis, but also the ability to interface with CT and MRI as well as PET images. The application of these capabilities into BioClinica’s technology will expand and improve on image registration and fusion capabilities in studies where multiple modalities are utilized.
BioClinica opted to enter into of a tactical partnership with Mirada, rather than simply utilizing their software, with the goal of fostering innovation while molecular imaging technology continues to progress. The integration of Mirada’s XD3 software into BioClinica’s processes and workflows will greatly augment the already substantial capabilities of BioClinica’s technologies such as BioPACS and BioREAD. The combination of these technologies will result in high performing imaging workflow and processing programs capable of helping trial sponsors take advantage of the superior imaging results made available through PET scans and multi-modal technology.
This partnership will allow BioClinica’s PET image processing capabilities to support the following features:
• Enhanced capabilities for PERCIST tumor response assessment criteria
• Normalization of uptake by body weight, lean body mass, or body surface area for SUV measurements
• Registration and fusion capabilities between PET, CT, and MR
• Customizable workflow and user interface to provide flexibility in the independent read design
“Adding Mirada technology to our oncology trial process takes BioClinica’s already robust imaging core lab services to a new level,” said Dr. Andy Dzik-Jurasz, BioClinica’s Senior Medical Director of Medical Affairs. “By adding XD3 to our workflow, BioClinica will offer the most sophisticated level of clinical analysis available for oncology PET scan image processing.”
“Mirada is delighted to partner with an innovative industry leader like BioClinica,” said Timor Kadir, Chief Science and Technology Officer at Mirada Medical. “We are excited to see BioClinica’s innovative utilization of XD3’s superior quantification and world class image fusion to achieve more accurate and reproducible results for their trial sponsors.”
As a result of this agreement, Mirada Medical will be presenting at BioClinica’s User Conference in October, a two day event featuring valuable presentations, case studies, and discussions aimed to help BioClinica imaging core lab customers and eClinical solutions users uncover methods producing faster, more efficient clinical trials.
To learn more about the conference, visit http://www.bioclinica.com/User-Conference-2012
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Mirada Medical’s XD3 software delivers specialized tools along with efficient workflows used for the quantification and tracking of findings for major modalities including PET, CT, MR, and MR/PET. BioClinica’s detailed evaluation of available molecular imaging solutions led to the selection of Mirada. Mirada offers not only cutting edge image analysis, but also the ability to interface with CT and MRI as well as PET images. The application of these capabilities into BioClinica’s technology will expand and improve on image registration and fusion capabilities in studies where multiple modalities are utilized.
BioClinica opted to enter into of a tactical partnership with Mirada, rather than simply utilizing their software, with the goal of fostering innovation while molecular imaging technology continues to progress. The integration of Mirada’s XD3 software into BioClinica’s processes and workflows will greatly augment the already substantial capabilities of BioClinica’s technologies such as BioPACS and BioREAD. The combination of these technologies will result in high performing imaging workflow and processing programs capable of helping trial sponsors take advantage of the superior imaging results made available through PET scans and multi-modal technology.
This partnership will allow BioClinica’s PET image processing capabilities to support the following features:
• Enhanced capabilities for PERCIST tumor response assessment criteria
• Normalization of uptake by body weight, lean body mass, or body surface area for SUV measurements
• Registration and fusion capabilities between PET, CT, and MR
• Customizable workflow and user interface to provide flexibility in the independent read design
“Adding Mirada technology to our oncology trial process takes BioClinica’s already robust imaging core lab services to a new level,” said Dr. Andy Dzik-Jurasz, BioClinica’s Senior Medical Director of Medical Affairs. “By adding XD3 to our workflow, BioClinica will offer the most sophisticated level of clinical analysis available for oncology PET scan image processing.”
“Mirada is delighted to partner with an innovative industry leader like BioClinica,” said Timor Kadir, Chief Science and Technology Officer at Mirada Medical. “We are excited to see BioClinica’s innovative utilization of XD3’s superior quantification and world class image fusion to achieve more accurate and reproducible results for their trial sponsors.”
As a result of this agreement, Mirada Medical will be presenting at BioClinica’s User Conference in October, a two day event featuring valuable presentations, case studies, and discussions aimed to help BioClinica imaging core lab customers and eClinical solutions users uncover methods producing faster, more efficient clinical trials.
To learn more about the conference, visit http://www.bioclinica.com/User-Conference-2012
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Guanwei Recycling Corp. (GPRC) Posts Record Financial Results for 2011
Guanwei Recycling, China’s leading clean tech manufacturer of recycled low density polyethylene (LDPE), today reported financial results for fiscal 2011, reflecting record sales and profits.
Net revenues for 2011 increased 34 percent to a record $63.6 million compared to $47.5 million reported a year earlier.
Net income in 2011 grew 29 percent to a record $12.7 million, or $0.64 per diluted share, compared with $9.9 million, or $0.50 per diluted share, reported in 2010.
Gross profit for 2011 increased approximately 27 percent to $19.48 million, while gross margins decreased to 30.64 percent from 32.20 percent a year earlier. The company attributes this decrease primarily to an approximately 22 percent increase in raw material costs.
The company increased its annual combined raw material import quota to 99,000 tons in 2011 and 115,000 tons in 2012; production capacity expanded to 80,000 tons from 65,000 tons.
As of December 31, 2011, Guanwei reported shareholders’ equity of $45 million, an increase compared to $34.1 million a year earlier. Total assets of $45.08 million at year end included cash and cash equivalents of $12.43 million, and accounts receivable of $4.48 million. Inventories increased to $16.85 million from $10.72 million a year earlier, and pre-payments and other assets of $2.10 million as of year-end 2011 compared with $475,195 at the end of 2010.
The company also paid off short-term debt and increased working capital at year end to $23.8 million from $13.4 million a year earlier.
Chen Min, chairman and CEO of Guanwei, called 2012 a “banner year” for the company, and noted increased production capacity, the company’s strong financial standing, and its obtaining of a substantial increase in its government quota for imported raw material.
“With these accomplishments,” Min stated in the press release, “we are confident of another year of record results in 2012. Even with an anticipated slowing in our domestic economy, we have a customer base that is well diversified, and the more than 40% price advantage our recycled plastic offers compared with virgin plastic continues to make it quite attractive.”
For more information visit www.guanweirecycling.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Net revenues for 2011 increased 34 percent to a record $63.6 million compared to $47.5 million reported a year earlier.
Net income in 2011 grew 29 percent to a record $12.7 million, or $0.64 per diluted share, compared with $9.9 million, or $0.50 per diluted share, reported in 2010.
Gross profit for 2011 increased approximately 27 percent to $19.48 million, while gross margins decreased to 30.64 percent from 32.20 percent a year earlier. The company attributes this decrease primarily to an approximately 22 percent increase in raw material costs.
The company increased its annual combined raw material import quota to 99,000 tons in 2011 and 115,000 tons in 2012; production capacity expanded to 80,000 tons from 65,000 tons.
As of December 31, 2011, Guanwei reported shareholders’ equity of $45 million, an increase compared to $34.1 million a year earlier. Total assets of $45.08 million at year end included cash and cash equivalents of $12.43 million, and accounts receivable of $4.48 million. Inventories increased to $16.85 million from $10.72 million a year earlier, and pre-payments and other assets of $2.10 million as of year-end 2011 compared with $475,195 at the end of 2010.
The company also paid off short-term debt and increased working capital at year end to $23.8 million from $13.4 million a year earlier.
Chen Min, chairman and CEO of Guanwei, called 2012 a “banner year” for the company, and noted increased production capacity, the company’s strong financial standing, and its obtaining of a substantial increase in its government quota for imported raw material.
“With these accomplishments,” Min stated in the press release, “we are confident of another year of record results in 2012. Even with an anticipated slowing in our domestic economy, we have a customer base that is well diversified, and the more than 40% price advantage our recycled plastic offers compared with virgin plastic continues to make it quite attractive.”
For more information visit www.guanweirecycling.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Uranium Energy Corp. (UEC) Closes Acquisition of Cue Resources Ltd.
This morning, Uranium Energy and CUE Resources Ltd. (TSX-V: CUE) announced that UEC’s acquisition of CUE by way of a plan of arrangement has officially closed. CUE is now a wholly-owned subsidiary of UEC. In exchange, UEC will issue 2,345,926 UEC common shares to former CUE shareholders as well as 171,303 UEC shares to settle certain debts of CUE. CUE, through its wholly-owned subsidiary, held an undivided 100% legal and beneficial interest in and to certain concession contracts covering a 230,650-hectare uranium exploration property located in southeastern Paraguay known as the Yuty ISR Project.
“Given the proximity of the Yuty project to our Coronel Oviedo property, this transaction enables clear operational synergies and allows us to consider implementing the hub-and-spoke production strategy we have successfully deployed in South Texas. We believe that Paraguay is host to a highly prospective, large-scale ISR-amenable uranium district with mineralization that is very similar to that of South Texas. In addition, consistent with other recent UEC project acquisitions, we have acquired an asset with an extensive defined resource at an attractive price. Given the 11-million pound total resource at Yuty, the Company now has both an exploration and development focus in this business-oriented, stable country. We’re excited about the opportunities that lie ahead,” stated President and CEO Amir Adnani.
Covering 230,650 hectares, the Yuty ISR Project is located approximately 200 kilometers east and southeast of Asunción, the capital of Paraguay. It is positioned within the Paraná Basin, which is host to a number of known uranium deposits, including Figueira and Amorinópolis in Brazil. Preliminary studies indicate amenability to extraction by in situ recovery (ISR) methods, which is the same process currently used by UEC at its South Texas operations. According to today’s press release, CUE has spent more than CAD$16 million developing Yuty since 2006.
Between 2007 and 2010, CUE completed 256 drill holes totaling 31,000 meters of core and rotary drilling and acquired a 100% interest in the Yuty Project. The current resource for the Yuty Project was finalized in a technical report prepared for CUE titled “Updated Technical Report on the Yuty Uranium Project, Republic of Paraguay” dated August 24, 2011. This report shows an average grade and resource at the Yuty Project as follows:
Measured Resource 2.054M tonnes @ 0.062 % eU3O8 containing 2.801M lbs eU3O8
Indicated Resource 5.783M tonnes @ 0.048 % eU3O8 containing 6.113M lbs eU3O8
Inferred Resource 2.139M tonnes @ 0.047 % eU3O8 containing 2.226M lbs eU3O8
Investors seeking additional information on the now completed plan of arrangement should see UEC’s news release dated January 23, 2012.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
“Given the proximity of the Yuty project to our Coronel Oviedo property, this transaction enables clear operational synergies and allows us to consider implementing the hub-and-spoke production strategy we have successfully deployed in South Texas. We believe that Paraguay is host to a highly prospective, large-scale ISR-amenable uranium district with mineralization that is very similar to that of South Texas. In addition, consistent with other recent UEC project acquisitions, we have acquired an asset with an extensive defined resource at an attractive price. Given the 11-million pound total resource at Yuty, the Company now has both an exploration and development focus in this business-oriented, stable country. We’re excited about the opportunities that lie ahead,” stated President and CEO Amir Adnani.
Covering 230,650 hectares, the Yuty ISR Project is located approximately 200 kilometers east and southeast of Asunción, the capital of Paraguay. It is positioned within the Paraná Basin, which is host to a number of known uranium deposits, including Figueira and Amorinópolis in Brazil. Preliminary studies indicate amenability to extraction by in situ recovery (ISR) methods, which is the same process currently used by UEC at its South Texas operations. According to today’s press release, CUE has spent more than CAD$16 million developing Yuty since 2006.
Between 2007 and 2010, CUE completed 256 drill holes totaling 31,000 meters of core and rotary drilling and acquired a 100% interest in the Yuty Project. The current resource for the Yuty Project was finalized in a technical report prepared for CUE titled “Updated Technical Report on the Yuty Uranium Project, Republic of Paraguay” dated August 24, 2011. This report shows an average grade and resource at the Yuty Project as follows:
Measured Resource 2.054M tonnes @ 0.062 % eU3O8 containing 2.801M lbs eU3O8
Indicated Resource 5.783M tonnes @ 0.048 % eU3O8 containing 6.113M lbs eU3O8
Inferred Resource 2.139M tonnes @ 0.047 % eU3O8 containing 2.226M lbs eU3O8
Investors seeking additional information on the now completed plan of arrangement should see UEC’s news release dated January 23, 2012.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Sinovac Biotech Ltd. (SVA) Phase I Clinical Data for EV71 Vaccine Against Hand, Foot, and Mouth Disease Published in Vaccine
Sinovac Biotech yesterday announced that the positive phase I clinical data for its proprietary inactivated Enterovirus 71 (EV71) vaccine was accepted for publication by Vaccine, a peer-reviewed journal. The uncorrected proof is available online.
The EV71 vaccine is an inoculation against hand, foot, and mouth disease (HFMD). The article, entitled “Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: A randomized, placebo-controlled, double-blind, Phase I clinical trial,” gives a detailed look at the safety observation with preliminary immunogenicity data from the study, in which all three age groups (adult, children, and infants) showed good safety and tolerance profiles.
During the phase I clinical trial, vaccine candidates were first given to the adults, starting from the lowest dosage to higher dosages. After the two inoculations were administered, a safety observation was conducted and clinical experts and the Data Safety Monitoring Committee reviewed the safety evaluation report. When safety was confirmed, inoculations were then administered to the children; the same procedure was followed before the infants were inoculated. The Ethics Committee approved this trial protocol.
The results of the phase I clinical trial showed that Sinovac’s novel inactivated human EV71 vaccine was well tolerated in healthy volunteers, and good immunogenicity was indicated in the testing results on neutralizing antibody. The company confirmed these findings in the phase II clinical trial, which showed that the EV71 vaccine demonstrated a good immunogenicity and a favorable safety profile with no serious vaccine-related adverse events.
In January, Sinovac commenced phase III clinical trials prior to the hand, foot, and mouth disease outbreak season. Around 10,000 healthy volunteers were enrolled through the end of March. The phase III trial is progressing on schedule and is anticipated to be completed in the first half of 2013. The construction of an EV71 vaccine production plant is also underway to be ready for production as soon as the vaccine is approved.
More than 90 percent of reported hand, foot, and mouth disease cases occur in children under the age of 5, and the epidemic situation is still serious in China. HFMD is common in childhood and usually mild, but there has been an increase in severe cases reported that are associated with neurological problems caused by EV71. Sinovac’s progress brings the world one step closer to a novel vaccine that is effective against human EV71 outbreaks.
Sinovac Biotech Ltd. is a biopharmaceutical company based in China. Sinovac’s focus is on researching, developing, manufacturing, and commercializing vaccines that protect against human infectious diseases, as well as animal rabies vaccines for canines. In 2009, Sinovac was the first company in the world to get approval for its H1N1 influenza vaccine, Panflu. 1. Sinovac has a number of new pipeline vaccines currently in development. The company primarily sells its vaccines in China, with some selected vaccines exported to Mongolia, Nepal, and the Philippines.
For more information, visit the company’s Web site at www.sinovac.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The EV71 vaccine is an inoculation against hand, foot, and mouth disease (HFMD). The article, entitled “Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: A randomized, placebo-controlled, double-blind, Phase I clinical trial,” gives a detailed look at the safety observation with preliminary immunogenicity data from the study, in which all three age groups (adult, children, and infants) showed good safety and tolerance profiles.
During the phase I clinical trial, vaccine candidates were first given to the adults, starting from the lowest dosage to higher dosages. After the two inoculations were administered, a safety observation was conducted and clinical experts and the Data Safety Monitoring Committee reviewed the safety evaluation report. When safety was confirmed, inoculations were then administered to the children; the same procedure was followed before the infants were inoculated. The Ethics Committee approved this trial protocol.
The results of the phase I clinical trial showed that Sinovac’s novel inactivated human EV71 vaccine was well tolerated in healthy volunteers, and good immunogenicity was indicated in the testing results on neutralizing antibody. The company confirmed these findings in the phase II clinical trial, which showed that the EV71 vaccine demonstrated a good immunogenicity and a favorable safety profile with no serious vaccine-related adverse events.
In January, Sinovac commenced phase III clinical trials prior to the hand, foot, and mouth disease outbreak season. Around 10,000 healthy volunteers were enrolled through the end of March. The phase III trial is progressing on schedule and is anticipated to be completed in the first half of 2013. The construction of an EV71 vaccine production plant is also underway to be ready for production as soon as the vaccine is approved.
More than 90 percent of reported hand, foot, and mouth disease cases occur in children under the age of 5, and the epidemic situation is still serious in China. HFMD is common in childhood and usually mild, but there has been an increase in severe cases reported that are associated with neurological problems caused by EV71. Sinovac’s progress brings the world one step closer to a novel vaccine that is effective against human EV71 outbreaks.
Sinovac Biotech Ltd. is a biopharmaceutical company based in China. Sinovac’s focus is on researching, developing, manufacturing, and commercializing vaccines that protect against human infectious diseases, as well as animal rabies vaccines for canines. In 2009, Sinovac was the first company in the world to get approval for its H1N1 influenza vaccine, Panflu. 1. Sinovac has a number of new pipeline vaccines currently in development. The company primarily sells its vaccines in China, with some selected vaccines exported to Mongolia, Nepal, and the Philippines.
For more information, visit the company’s Web site at www.sinovac.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Sanchez Energy Corp. (SN) Reports Fourth Quarter Operational Results
Sanchez Energy reported operational details on the company’s recent oil and gas exploration and development activity in the United States. The company also released financial results for the quarter ending December 31, 2011.
Sanchez Energy reported total oil and gas production of 56,007 barrels of oil equivalent (BOE) in the fourth quarter of 2011. This production level represented growth of 41% sequentially and 38% on a year-over-year basis.
Sanchez Energy is currently operating three rigs on the company’s oil and gas properties in south Texas, where the company is testing the Eagle Ford Shale and Austin Chalk formations. The company said that a recent vertical well on its acreage produced at a production rate of 207 BOE per day during an initial test period.
Sanchez Energy reported sales of $4.6 million in the fourth quarter of 2011, up 50% from the $3.1 million reported in the corresponding quarter of 2010. The company realized a price of $102.32 per barrel for crude oil and $2.37 per thousand cubic feet for natural gas.
Sanchez Energy has 92,000 net acres under lease and plans to drill 16.5 net wells in 2012. The company has set a capital budget between $136 million and $154 million for the year.
For more information on the company, go to www.sanchezenergycorp.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Sanchez Energy reported total oil and gas production of 56,007 barrels of oil equivalent (BOE) in the fourth quarter of 2011. This production level represented growth of 41% sequentially and 38% on a year-over-year basis.
Sanchez Energy is currently operating three rigs on the company’s oil and gas properties in south Texas, where the company is testing the Eagle Ford Shale and Austin Chalk formations. The company said that a recent vertical well on its acreage produced at a production rate of 207 BOE per day during an initial test period.
Sanchez Energy reported sales of $4.6 million in the fourth quarter of 2011, up 50% from the $3.1 million reported in the corresponding quarter of 2010. The company realized a price of $102.32 per barrel for crude oil and $2.37 per thousand cubic feet for natural gas.
Sanchez Energy has 92,000 net acres under lease and plans to drill 16.5 net wells in 2012. The company has set a capital budget between $136 million and $154 million for the year.
For more information on the company, go to www.sanchezenergycorp.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Zogenix, Inc. (ZGNX) and Battelle Partner to Progress New DosePro Applications Offering Proven Needle-Free Subcutaneous Drug Delivery to Bio-Parma Community
Zogenix, a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, and Battelle, the world’s largest independent research and development organization, completed their previously announced synergistic agreement to further cultivate out-licensing opportunities and development of Zogenix’s DosePro® drug delivery technology. Battelle and Zogenix will work together to market DosePro technology hoping to license the system to pharmaceutical clients who seek to enhance the use of innovative therapeutics by combining them with DosePro’s proprietary needle-free delivery system.
DosePro technology provides pre-filled, single-use, disposable, needle-free drug delivery. This method for drug delivery offers significant increases in safety and convenience for the patient over existing needle-based injection delivery systems. In addition to providing an improved experience for the patient, DosePro may also provide an avenue to overcome major roadblocks in the delivery of viscous drug formulations, such as high concentration biologics, which cannot be delivered with current needle-based injection technology.
The intellectual property incorporated into DosePro drug delivery technology is covered through 2026 by more than 46 internationally issued patents, and Zogenix has already received approval for, in the United States and Europe, and produced over 1.5 million units of SUMAVEL® DosePro®, the company’s migraine therapy. Feedback from patients has shown that patients desire to switch from oral to injectable delivery if given the option of using DosePro technology, even though needle-based delivery has been an option for over 10 years.
John Turanin, Vice President and General Manager, DosePro Technology, at Zogenix, states, “Battelle has a strong reputation for product development that has earned them a ‘who’s who’ client list in the pharmaceutical industry. Collaborating on DosePro provides additional support of our technology and the backing of a significant technical business partner. We expect the out-licensing effort to accelerate now that we are working with Battelle. We have already trained their business development team and are expanding laboratory capabilities to begin working on DosePro product candidates.”
Barbara Kunz, President of Battelle Health and Life Sciences Global Business, said, “This collaboration enables Battelle to expand our platform of innovative drug delivery solutions to our pharmaceutical customers. We believe DosePro will be able to assist our clients with addressing many of the challenges they face today, in particular, the delivery of highly viscous drug formulations.”
The marketing strategy employed by Battelle for the DosePro technology involves reaching potential customers through strategic product planning meetings, at conferences, in trade publications, and through other marketing communications. There is a joint effort between the technical teams from both companies to establish a center of excellence for DosePro technology development and testing. Another feature of this agreement is Battelle’s option to jointly develop and commercialize an iteration of DosePro technology with Zogenix. This next step in DosePro technology delivers a larger, 1.2mL, dose as opposed to the current dose size of 0.5mL.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
DosePro technology provides pre-filled, single-use, disposable, needle-free drug delivery. This method for drug delivery offers significant increases in safety and convenience for the patient over existing needle-based injection delivery systems. In addition to providing an improved experience for the patient, DosePro may also provide an avenue to overcome major roadblocks in the delivery of viscous drug formulations, such as high concentration biologics, which cannot be delivered with current needle-based injection technology.
The intellectual property incorporated into DosePro drug delivery technology is covered through 2026 by more than 46 internationally issued patents, and Zogenix has already received approval for, in the United States and Europe, and produced over 1.5 million units of SUMAVEL® DosePro®, the company’s migraine therapy. Feedback from patients has shown that patients desire to switch from oral to injectable delivery if given the option of using DosePro technology, even though needle-based delivery has been an option for over 10 years.
John Turanin, Vice President and General Manager, DosePro Technology, at Zogenix, states, “Battelle has a strong reputation for product development that has earned them a ‘who’s who’ client list in the pharmaceutical industry. Collaborating on DosePro provides additional support of our technology and the backing of a significant technical business partner. We expect the out-licensing effort to accelerate now that we are working with Battelle. We have already trained their business development team and are expanding laboratory capabilities to begin working on DosePro product candidates.”
Barbara Kunz, President of Battelle Health and Life Sciences Global Business, said, “This collaboration enables Battelle to expand our platform of innovative drug delivery solutions to our pharmaceutical customers. We believe DosePro will be able to assist our clients with addressing many of the challenges they face today, in particular, the delivery of highly viscous drug formulations.”
The marketing strategy employed by Battelle for the DosePro technology involves reaching potential customers through strategic product planning meetings, at conferences, in trade publications, and through other marketing communications. There is a joint effort between the technical teams from both companies to establish a center of excellence for DosePro technology development and testing. Another feature of this agreement is Battelle’s option to jointly develop and commercialize an iteration of DosePro technology with Zogenix. This next step in DosePro technology delivers a larger, 1.2mL, dose as opposed to the current dose size of 0.5mL.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Thursday, March 29, 2012
Compugen Ltd. (CGEN) Announces San Francisco Operations for Developing Monoclonal Antibody Drug Candidates
Yesterday, leading therapeutic product discovery company Compugen, Inc. announced it has established development operations in South San Francisco for oncology and immunology monoclonal antibody (mAb) drug candidates against targets discovered by parent company Compugen Ltd.
Additionally, Compugen Ltd. announced the appointment of Mary Haak-Frendscho, Ph.D. as the executive chairperson of Compugen, Inc. and John J. Hunter, Ph.D. as the company’s site head and vice president of antibody R&D, effective April 1.
Compugen, Inc.’s new South San Francisco operations will be located in purpose-built facilities with relevant laboratory equipment recently secured by the company. Strategically placing its mAb operations in the birthplace of biotech will give the company access to some of the best biologics talents in the industry, as well as supportive infrastructure. It is anticipated that these new capabilities will additionally increase the number of mAb product candidates developed against novel Compugen-discovered targets, as the company will be able to perform key activities more efficiently in-house compared to exclusively using third parties as previously intended.
Compugen is an industry leader in therapeutic product discovery, and the company’s focus is on therapeutic proteins and monoclonal antibodies to address unmet needs in the immunology and oncology fields for Compugen and its partners. The company’s discovery efforts are based on systematic in silico (by computer) product candidate prediction and selection followed by experimental validation, with selected product candidates being advanced in the company’s pipeline program to the pre-IND stage.
Compugen’s business model chiefly involves collaborations that cover the further development and commercialization of Compugen-discovered product candidates and various forms of research and discovery agreements – both resulting in potential milestone payments, product sales royalties, and other forms of revenue sharing for Compugen.
For more information, visit the company’s corporate Web site at www.cgen.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Additionally, Compugen Ltd. announced the appointment of Mary Haak-Frendscho, Ph.D. as the executive chairperson of Compugen, Inc. and John J. Hunter, Ph.D. as the company’s site head and vice president of antibody R&D, effective April 1.
Compugen, Inc.’s new South San Francisco operations will be located in purpose-built facilities with relevant laboratory equipment recently secured by the company. Strategically placing its mAb operations in the birthplace of biotech will give the company access to some of the best biologics talents in the industry, as well as supportive infrastructure. It is anticipated that these new capabilities will additionally increase the number of mAb product candidates developed against novel Compugen-discovered targets, as the company will be able to perform key activities more efficiently in-house compared to exclusively using third parties as previously intended.
Compugen is an industry leader in therapeutic product discovery, and the company’s focus is on therapeutic proteins and monoclonal antibodies to address unmet needs in the immunology and oncology fields for Compugen and its partners. The company’s discovery efforts are based on systematic in silico (by computer) product candidate prediction and selection followed by experimental validation, with selected product candidates being advanced in the company’s pipeline program to the pre-IND stage.
Compugen’s business model chiefly involves collaborations that cover the further development and commercialization of Compugen-discovered product candidates and various forms of research and discovery agreements – both resulting in potential milestone payments, product sales royalties, and other forms of revenue sharing for Compugen.
For more information, visit the company’s corporate Web site at www.cgen.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Network Equipment Technologies, Inc. (NWK) and BT Partner to Offer Simplified Unified Communications Solutions for Microsoft ® Lync 2010 Deployments
Network Equipment Technologies announced it would be entering into a strategic partnership with BT. This initiative will serve to considerably simplify the deployment and installation of Microsoft Lync 2010, significantly reducing the time and effort required for service providers and large enterprises to implement advanced unified communications (UC) solutions. With the use of NET’s Unified Exchange (UX) Series platform, BT will be capable of providing superior managed and professional solutions that enhance the performance of on-premise enterprise application systems.
“Businesses are seeking ways to reduce costs, increase productivity, and improve customer service. Being able to communicate and collaborate with anyone at any time, whether you are using phone, e-mail, application sharing, messaging or conferencing is key to achieving these goals,” said Matthew Krueger, Vice President Business Development at NET. “The combined BT and NET solution offers customers an innovative option to the challenge of deploying UC and cloud-based managed services.”
NET’s UX Series cutting edge mediation platform is based on a modular 1U platform that was constructed for unified communications and enterprise session border controller applications. The UX Series session mediation platform makes the purchase of separate infrastructure components unnecessary, reducing both capital and operational expenses. The UX Series is qualified as an enterprise Survivable Branch Appliance for Microsoft® Lync™ 2010.
BT’s Managed Lync solution delivers the convenience of originally separate technologies onto one platform without the need for an entirely new infrastructure. The partnership between NET and BT will strengthen BT’s current global Managed Lync services. By merging voice and data communications onto a single platform, BT can offer customers higher efficiencies for their staff while also reducing the cost of call and data transmission and management.
“This initiative was designed to address the unique customer requirements for a Lync-based ‘cloud’ managed service,” said Randy Schrock, Vice President, Corporate Alliances, BT Global Services. “We’re excited to be able to introduce NET’s UX Series products as part of our Microsoft Lync solution strategy in order to help our customers benefit from improved unified communications productivity at substantially lower costs. This initiative with NET expands both our professional and managed service solutions we offer to U.S. domestic customers and complements our global strategic approach by continuing to drive innovation and business value into our core network services.”
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
“Businesses are seeking ways to reduce costs, increase productivity, and improve customer service. Being able to communicate and collaborate with anyone at any time, whether you are using phone, e-mail, application sharing, messaging or conferencing is key to achieving these goals,” said Matthew Krueger, Vice President Business Development at NET. “The combined BT and NET solution offers customers an innovative option to the challenge of deploying UC and cloud-based managed services.”
NET’s UX Series cutting edge mediation platform is based on a modular 1U platform that was constructed for unified communications and enterprise session border controller applications. The UX Series session mediation platform makes the purchase of separate infrastructure components unnecessary, reducing both capital and operational expenses. The UX Series is qualified as an enterprise Survivable Branch Appliance for Microsoft® Lync™ 2010.
BT’s Managed Lync solution delivers the convenience of originally separate technologies onto one platform without the need for an entirely new infrastructure. The partnership between NET and BT will strengthen BT’s current global Managed Lync services. By merging voice and data communications onto a single platform, BT can offer customers higher efficiencies for their staff while also reducing the cost of call and data transmission and management.
“This initiative was designed to address the unique customer requirements for a Lync-based ‘cloud’ managed service,” said Randy Schrock, Vice President, Corporate Alliances, BT Global Services. “We’re excited to be able to introduce NET’s UX Series products as part of our Microsoft Lync solution strategy in order to help our customers benefit from improved unified communications productivity at substantially lower costs. This initiative with NET expands both our professional and managed service solutions we offer to U.S. domestic customers and complements our global strategic approach by continuing to drive innovation and business value into our core network services.”
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
RadNet, Inc. (RDNT) and Barnabas Health Form Joint Venture
Recently, RadNet and Barnabas Health announced that they have formed a multi-faceted Joint Venture to pursue opportunities in diagnostic imaging and related businesses within New Jersey. The Joint Venture is slated to begin operations this summer with 37 patient access points across the state of New Jersey.
The companies’ Joint Venture will establish a statewide diagnostic imaging network, exclusively contracting on behalf of its imaging network with regional payors, including commercial insurance companies, utilization and radiology benefit managers, workers compensation carriers, and all other health plans and local insurers. It will also provide management services to the existing RadNet and Barnabas imaging facilities to include information technology, marketing, utilization review, billing and collecting, transcription, medical records management, equipment maintenance, purchasing, and insurance.
Additionally, the Joint Venture will satisfy the companies’ ultimate objective of reducing costs and improving quality of service and patient care throughout their facilities. The companies anticipate that it can expand its management and contracting services to include third-party imaging centers and inpatient hospital radiology departments in the future. RadNet and Barnabas see opportunities to move into new markets through the Joint Venture, particularly in the fields of medical oncology, comprehensive breast disease management, teleradiology, information technology, and clinical trials work.
Dr. Howard Berger, President and Chief Executive Officer of RadNet, remarked, “We are very pleased to announce our new relationship with Barnabas Health. With the advent of Accountable Care Organizations (ACOs), whose goal it is to improve integration among healthcare providers, our venture is an important step towards delivering a fully integrated imaging network that provides convenient, high quality, cost effective and patient centric medical imaging solutions for the medical communities of New Jersey. Barnabas Health is a premier hospital system in New Jersey. By combining its existing market presence with RadNet’s expertise and existing New Jersey outpatient imaging centers, we are convinced that our collaboration will drive benefits to patient care. In the process, we believe that improving patient care will inure financial benefits to both RadNet and Barnabas Health.”
Barry H. Ostrowsky, Barnabas’ President and CEO, added, “Forming a Joint Venture with RadNet, an experienced leader in the field of diagnostic imaging, provides an exciting opportunity for Barnabas Health and the two million patients we serve annually. Our core values embrace high quality services, cost effectiveness and patient satisfaction. We have built our national reputation on providing best practices in medicine with the focus on ensuring patient access in urban and suburban, inpatient and outpatient settings. The Joint Venture with RadNet further strengthens our mission of providing the finest healthcare for all.”
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The companies’ Joint Venture will establish a statewide diagnostic imaging network, exclusively contracting on behalf of its imaging network with regional payors, including commercial insurance companies, utilization and radiology benefit managers, workers compensation carriers, and all other health plans and local insurers. It will also provide management services to the existing RadNet and Barnabas imaging facilities to include information technology, marketing, utilization review, billing and collecting, transcription, medical records management, equipment maintenance, purchasing, and insurance.
Additionally, the Joint Venture will satisfy the companies’ ultimate objective of reducing costs and improving quality of service and patient care throughout their facilities. The companies anticipate that it can expand its management and contracting services to include third-party imaging centers and inpatient hospital radiology departments in the future. RadNet and Barnabas see opportunities to move into new markets through the Joint Venture, particularly in the fields of medical oncology, comprehensive breast disease management, teleradiology, information technology, and clinical trials work.
Dr. Howard Berger, President and Chief Executive Officer of RadNet, remarked, “We are very pleased to announce our new relationship with Barnabas Health. With the advent of Accountable Care Organizations (ACOs), whose goal it is to improve integration among healthcare providers, our venture is an important step towards delivering a fully integrated imaging network that provides convenient, high quality, cost effective and patient centric medical imaging solutions for the medical communities of New Jersey. Barnabas Health is a premier hospital system in New Jersey. By combining its existing market presence with RadNet’s expertise and existing New Jersey outpatient imaging centers, we are convinced that our collaboration will drive benefits to patient care. In the process, we believe that improving patient care will inure financial benefits to both RadNet and Barnabas Health.”
Barry H. Ostrowsky, Barnabas’ President and CEO, added, “Forming a Joint Venture with RadNet, an experienced leader in the field of diagnostic imaging, provides an exciting opportunity for Barnabas Health and the two million patients we serve annually. Our core values embrace high quality services, cost effectiveness and patient satisfaction. We have built our national reputation on providing best practices in medicine with the focus on ensuring patient access in urban and suburban, inpatient and outpatient settings. The Joint Venture with RadNet further strengthens our mission of providing the finest healthcare for all.”
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
AdCare Health Systems, Inc. (ADK) is Successful with Diverse Property Portfolio
AdCare Health Systems, an aggressively expanding owner and operator of living and care facilities in 7 states, believes that a significant part of its success is due to the fact that it treats every newly acquired property as a unique entity, requiring a unique approach to improve its operational income and ultimate value.
The company now controls approximately 44 properties in Alabama, Arkansas, Georgia, Missouri, North Carolina, Ohio, and Oklahoma, with over 4,000 employees. The facilities are either owned or leased by AdCare, or, in some cases, they are managed for third parties such as corporations or independent owners. As a result, AdCare has garnered extensive experience in all aspects of senior living facility ownership and management, including operation, design, and development consultation, as well as in the provision of interim administrator and/or director of nursing, for all sizes and types of properties.
• Independent Living – AdCare’s independent campuses provide people the freedom in their retirement years to achieve personal goals.
• Assisted Living – Through their Hearth & Home design program, AdCare has created spaces where the individual spirit is nourished.
• Skilled Nursing – AdCare prides itself in the superior care and services provided by their nursing homes.
• Dementia Care – AdCare provides special programs for residents with dementia, offering the highest possible quality of life and care.
AdCare’s fast-paced acquisition run has targeted under-performing low-margin properties, which are then turned around, partly through transitioning them over to higher-margin acute care facilities. The management team, which controls over 25% of the company’s common stock, has worked hard to grow AdCare’s administrative infrastructure, so that they are always able to handle the growth.
It’s a formula that continues to work for AdCare, generating a string of record revenues and income. 2011 was the company’s best year ever, with revenue up 198% from 2010 and annual income from operations jumping to $2.7 million. So far, 2012 is on track to be even better.
For additional information, visit the company’s website at www.AdCareHealth.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The company now controls approximately 44 properties in Alabama, Arkansas, Georgia, Missouri, North Carolina, Ohio, and Oklahoma, with over 4,000 employees. The facilities are either owned or leased by AdCare, or, in some cases, they are managed for third parties such as corporations or independent owners. As a result, AdCare has garnered extensive experience in all aspects of senior living facility ownership and management, including operation, design, and development consultation, as well as in the provision of interim administrator and/or director of nursing, for all sizes and types of properties.
• Independent Living – AdCare’s independent campuses provide people the freedom in their retirement years to achieve personal goals.
• Assisted Living – Through their Hearth & Home design program, AdCare has created spaces where the individual spirit is nourished.
• Skilled Nursing – AdCare prides itself in the superior care and services provided by their nursing homes.
• Dementia Care – AdCare provides special programs for residents with dementia, offering the highest possible quality of life and care.
AdCare’s fast-paced acquisition run has targeted under-performing low-margin properties, which are then turned around, partly through transitioning them over to higher-margin acute care facilities. The management team, which controls over 25% of the company’s common stock, has worked hard to grow AdCare’s administrative infrastructure, so that they are always able to handle the growth.
It’s a formula that continues to work for AdCare, generating a string of record revenues and income. 2011 was the company’s best year ever, with revenue up 198% from 2010 and annual income from operations jumping to $2.7 million. So far, 2012 is on track to be even better.
For additional information, visit the company’s website at www.AdCareHealth.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
China TransInfo Technology Corp. (CTFO) Reports Fourth Quarter and Full Year 2011 Results
China TransInfo Technology Corp. is a leading provider of comprehensive intelligent urban and highway transportation systems in China. The company is a leading transportation information products and solutions vendor and aims to be the largest real-time transportation information and major fleet management service provider in China.
The company has successfully developed a first-generation vehicle monitoring and control platform for the Ministry of Transportation. To date, it has recorded more than 1.32 million vehicles registered on the platform and recorded roughly 460,000 active users. China TransInfo has also recently brought into operation its Freight Transport Safety Information Monitoring and Services System as well as the Passenger Coach Public Service Platform.
China TransInfo today announced financial results for both the fourth quarter and full year 2011. Revenues in the fourth quarter increased 24.3% year-over-year to $48.2 million from $38.8 million. The increase in revenue was driven primarily by a strong performance in the highway IT services division. That solid performance also drove full year revenues up by 36.1% to $167 million from $122.7 million in the year ago period. Adjusted net income for the fourth quarter came in at $5.1 million or 20 cents per share. For 2011 as a whole, adjusted net income came in at $15.1 million or 60 cents a share.
The company has received a preliminary proposal from its chairman and CEO, Shudong Xia, to take the company private. He stated that he is willing to offer $5.65 a share in cash for all the outstanding shares. Mr. Xia already owns 27.85% of the common stock.
For additional information about China TransInfo Technology, please visit the company’s website at www.chinatransinfo.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The company has successfully developed a first-generation vehicle monitoring and control platform for the Ministry of Transportation. To date, it has recorded more than 1.32 million vehicles registered on the platform and recorded roughly 460,000 active users. China TransInfo has also recently brought into operation its Freight Transport Safety Information Monitoring and Services System as well as the Passenger Coach Public Service Platform.
China TransInfo today announced financial results for both the fourth quarter and full year 2011. Revenues in the fourth quarter increased 24.3% year-over-year to $48.2 million from $38.8 million. The increase in revenue was driven primarily by a strong performance in the highway IT services division. That solid performance also drove full year revenues up by 36.1% to $167 million from $122.7 million in the year ago period. Adjusted net income for the fourth quarter came in at $5.1 million or 20 cents per share. For 2011 as a whole, adjusted net income came in at $15.1 million or 60 cents a share.
The company has received a preliminary proposal from its chairman and CEO, Shudong Xia, to take the company private. He stated that he is willing to offer $5.65 a share in cash for all the outstanding shares. Mr. Xia already owns 27.85% of the common stock.
For additional information about China TransInfo Technology, please visit the company’s website at www.chinatransinfo.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Pyramid Oil Company (PDO) Reports Strong Financials, Projects Further Growth amid Rising Oil Prices, Expanding Operations
Today, veteran oil and gas sector developer Pyramid Oil, which has been fielding acreage candidates and drilling wells since 1909, punched out some very nice FY11 and Q4 (ended Dec 31, 2011) financial data.
FY11 data offers a clear view of the company’s solid growth vector:
• Sales – up 26% to $5.7M (from $4.5M in 2010)
• Total Revenue – up 18% to $5.7M (from $4.8M)
• EPS – up 359% to $0.23 (from $0.05)
• Operating Cash Flow – up 47.1% to $2.5M (from $1.7M)
• Cash, Cash Equivalents, and Short-Term Investments – up 30.4% to $6M (from $4.6M)
• Long-Term Debt – under $25k
• Total Current Assets – $7.2M, with $6.5M in working capital and a ratio of 10:1
Sales rose on the strength of rising prices, which were up 38.8% per average BOE, to $104.78 (from $76.04 in 2010). Revenue data here is especially nice when considering that a portion of total revenue in 2010 was attributable to the $321k gain in Q3 from sale of a portion of PDO interests in a Texas gas venture.
Serious bottom-line growth was obtained by the company through this period, with operating income up sharply to $1.2M, compared to just $54k in 2010, even though there was some $727k in non-cash valuation allowances in 2011 (attributable to two new wells that failed to meet anticipated production results).
President and CEO of PDO, John Alexander, cited the sustained strength of the price environment for crude, combined with the company’s lean cost structure and production from PDO’s core properties, as making the 2011 report the most powerful in years. Projected exploratory operations and analysis of drilling prospects for 2012 on company leases in Kern County, CA, in conjunction with broader evaluation of external growth opportunities, will join with ongoing drilling at the company’s Carneros Creek property on Santa Fe #20 (started Q1 this year and projected to wrap up within days), leading to as many as three wells thus far PDO looks to drill this year (depending on rig availability).
The Q4 data rounds things out, with crude oil prices revenue and operating income in line with the year-long data:
• Total Revenue – up 18% to $1.4M (from $1.2M in Q4 FY10; 32.5% increase avg. BOE price)
• Operating Income – $435k compared to a loss of $91k
• Net Income and EPS – $344k, or $0.07/share, compared to a net loss of $27k, or $0.01/share
Even with ICE-traded oil futures for 2015 Brent off by almost $30, it is very clear that the underlying fundamentals do not support cheaper oil, and as we clear the middle of the week, France, the US, and the UK are even in talks about a possible release of strategic oil stocks. With Iran slated to drop serious capacity by the end of the month (as much as 14%), the EU embargo on Iranian oil only three months away, and US/EU sanctions being prepped with the aim of shutting down Iran’s nuclear program, the immediate vectors are clear. Even as crude throughput rises, serious shortfalls in global refining capacity continually crop up on the radar.
For more information on the financials, or to learn more about Pyramid Oil Company, please visit the company’s website at: www.PyramidOil.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
FY11 data offers a clear view of the company’s solid growth vector:
• Sales – up 26% to $5.7M (from $4.5M in 2010)
• Total Revenue – up 18% to $5.7M (from $4.8M)
• EPS – up 359% to $0.23 (from $0.05)
• Operating Cash Flow – up 47.1% to $2.5M (from $1.7M)
• Cash, Cash Equivalents, and Short-Term Investments – up 30.4% to $6M (from $4.6M)
• Long-Term Debt – under $25k
• Total Current Assets – $7.2M, with $6.5M in working capital and a ratio of 10:1
Sales rose on the strength of rising prices, which were up 38.8% per average BOE, to $104.78 (from $76.04 in 2010). Revenue data here is especially nice when considering that a portion of total revenue in 2010 was attributable to the $321k gain in Q3 from sale of a portion of PDO interests in a Texas gas venture.
Serious bottom-line growth was obtained by the company through this period, with operating income up sharply to $1.2M, compared to just $54k in 2010, even though there was some $727k in non-cash valuation allowances in 2011 (attributable to two new wells that failed to meet anticipated production results).
President and CEO of PDO, John Alexander, cited the sustained strength of the price environment for crude, combined with the company’s lean cost structure and production from PDO’s core properties, as making the 2011 report the most powerful in years. Projected exploratory operations and analysis of drilling prospects for 2012 on company leases in Kern County, CA, in conjunction with broader evaluation of external growth opportunities, will join with ongoing drilling at the company’s Carneros Creek property on Santa Fe #20 (started Q1 this year and projected to wrap up within days), leading to as many as three wells thus far PDO looks to drill this year (depending on rig availability).
The Q4 data rounds things out, with crude oil prices revenue and operating income in line with the year-long data:
• Total Revenue – up 18% to $1.4M (from $1.2M in Q4 FY10; 32.5% increase avg. BOE price)
• Operating Income – $435k compared to a loss of $91k
• Net Income and EPS – $344k, or $0.07/share, compared to a net loss of $27k, or $0.01/share
Even with ICE-traded oil futures for 2015 Brent off by almost $30, it is very clear that the underlying fundamentals do not support cheaper oil, and as we clear the middle of the week, France, the US, and the UK are even in talks about a possible release of strategic oil stocks. With Iran slated to drop serious capacity by the end of the month (as much as 14%), the EU embargo on Iranian oil only three months away, and US/EU sanctions being prepped with the aim of shutting down Iran’s nuclear program, the immediate vectors are clear. Even as crude throughput rises, serious shortfalls in global refining capacity continually crop up on the radar.
For more information on the financials, or to learn more about Pyramid Oil Company, please visit the company’s website at: www.PyramidOil.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Vertex Energy, Inc. (VTNR) Posts Q4, FY 2011 Financial Results
Vertex Energy, a leading environmental services company that recycles industrial waste streams and off-specification commercial chemical products, today announced its financial results for the fourth quarter and full year ended December 31, 2011.
Fourth quarter revenue increased nearly 100 percent to $31.3 million for 2011 compared with $15.7 million in revenue reported for the fourth quarter of 2010.
Gross profit was $1.31 million compared with $1.48 million during the fourth quarter of 2010.
Income from operations was $235,829 compared with $510,205 during the fourth quarter of 2010.
Net income was $2.1 million compared to $467,280 in last year’s fourth quarter; $1.8 million of this increase is attributable to the tax benefit stemming from the net operating losses related largely to the World Waste Technologies merger.
Vertex’ sales volumes improved 29 percent in the fourth quarter of 2011 compared to the fourth quarter of 2010.
“While the fourth quarter income results were behind last year’s fourth quarter, we are entering the new year in a position of strength. We believe improvements will continue into 2012, and expect the first quarter 2012 to outperform the first quarter of 2011,” Benjamin P. Cowart, CEO of Vertex stated in the press release.
Full-year 2011 revenues increased 89 percent to $109.7 million for the year ended 2011 compared with $58.1 million in 2010.
Gross profit increased to $8.1 million, a 90 percent increase over the $4.2 million reported in 2010.
Income from operations improved 247 percent to $4.0 million, compared with $1.1 million reported last year.
Net income improved to $5.8 million or $0.39 per fully diluted share, compared with net income of $1.2 million, or $0.09 per fully diluted share, reported in 2010; net income for the 2011 year includes a $1.8 million tax benefit, primarily stemming from the company’s net operating losses related to the 2009 World Waste Technologies merger.
Company-wide sales volumes increased 26 percent over 2010.
According to Cowart, Vertex is moving through 2012 with “relatively no long-term debt, significantly increased cash flow, and advantageous market conditions” as the company continues to explore strategic acquisitions for further growth.
For more information on the company visit www.vertexenergy.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Fourth quarter revenue increased nearly 100 percent to $31.3 million for 2011 compared with $15.7 million in revenue reported for the fourth quarter of 2010.
Gross profit was $1.31 million compared with $1.48 million during the fourth quarter of 2010.
Income from operations was $235,829 compared with $510,205 during the fourth quarter of 2010.
Net income was $2.1 million compared to $467,280 in last year’s fourth quarter; $1.8 million of this increase is attributable to the tax benefit stemming from the net operating losses related largely to the World Waste Technologies merger.
Vertex’ sales volumes improved 29 percent in the fourth quarter of 2011 compared to the fourth quarter of 2010.
“While the fourth quarter income results were behind last year’s fourth quarter, we are entering the new year in a position of strength. We believe improvements will continue into 2012, and expect the first quarter 2012 to outperform the first quarter of 2011,” Benjamin P. Cowart, CEO of Vertex stated in the press release.
Full-year 2011 revenues increased 89 percent to $109.7 million for the year ended 2011 compared with $58.1 million in 2010.
Gross profit increased to $8.1 million, a 90 percent increase over the $4.2 million reported in 2010.
Income from operations improved 247 percent to $4.0 million, compared with $1.1 million reported last year.
Net income improved to $5.8 million or $0.39 per fully diluted share, compared with net income of $1.2 million, or $0.09 per fully diluted share, reported in 2010; net income for the 2011 year includes a $1.8 million tax benefit, primarily stemming from the company’s net operating losses related to the 2009 World Waste Technologies merger.
Company-wide sales volumes increased 26 percent over 2010.
According to Cowart, Vertex is moving through 2012 with “relatively no long-term debt, significantly increased cash flow, and advantageous market conditions” as the company continues to explore strategic acquisitions for further growth.
For more information on the company visit www.vertexenergy.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Wednesday, March 28, 2012
Asia Entertainment & Resources Ltd. (AERL) Shows Solid Financials, Growth-Driven VIP Gaming Model Focused on Booming Macau Casino Sector
Asia Entertainment & Resources has rapidly emerged as a premier organizer/promoter of VIP gaming, primarily in what is arguably the Las Vegas of South China, Macau. Macau has a relatively small population of just 540k but is only 37 miles across the Zhujiang River Estuary from Hong Kong and plays host to massive liquidity in the Chinese economy, making it a booming casino city.
The growing wealth, income gap, and relaxed monetary policies of modern China are priming the pump for explosive growth of the Casino/Gaming sector in Macau, and AERL is ideally positioned to profit from this growth. Investors are taking note of the potential AERL has as a leading promoter of VIP gaming, with solid ties to key locations in Macao’s hottest venues, like the Galaxy Star World Casino in downtown Macau (12 tables), in addition to the Venetian Macao-Resort-Hotel (5 tables) and Galaxy Cotai (12 tables), both on the famous Cotai Strip.
The Cotai Strip is like the Las Vegas Strip and is the epicenter of tourism and gaming activity in Macau. A main reason for the company’s success has been to know where the action is and how to secure marketing/agreements. With 20-year veteran gaming industry management at the helm, AERL has been able to amass an impressive portfolio of over 1,600 agents/collaborators across Asia, crystallizing renewable agreements, yet achieving a very flexible, extensible framework for the business model.
Huge leeway to move to and add new casino locations, combined with a solid performance record, is generating substantial buzz for AERL. Top investment banking, securities, and investment management firm Maxim Group recently initiated coverage on AERL with a Buy rating and $12 price target, joining the list of other current Buy rating analysts at Janney Montgomery Scott, Sterne Agee, and Stifel Nicolaus.
A closer look at the annual audit and financial filings for fiscal 2011 confirm this solid outlook, with AERL reporting a 97% increase in revenues for the year over 2010 figures, with the two primary factors being a 91% jump in rolling chip turnover, and a 99% increase in adjusted net income (non-GAAP). Guidance offered indicates rolling chip turnover of $24.96B and adjusted net income (non-GAAP) in the $88-95M neighborhood for 2012.
That’s a very nice neighborhood to be in and the markets have taken note of the cherry fundamentals and obvious underlying dynamics, eyeing AERL as a perfect way to catch some of the heat from China’s overflowing economic cauldron.
The AERL Board approved a $0.10 per share semi-annual dividend after six-month financials were reported recently, subsequently also approving a 20% raise to $0.12, beginning with the first six-month dividend for 2012. Naturally, as this total dividend is some 15% of EBITDA, increased cash flows year-over-year will drive the figure higher, a likely possibility given the nature of the operations and AERL’s performance vectors.
Asia Entertainment & Resources is generating serious profitability and offers the kind of real discount profile that has investors buzzing (2.8x for 2012 P/E ratio). Maxim Group’s endorsement pegs the fundamentals as having a great future, and it is easy to see why the future of the gaming sector in Macau will continue to grow on the heels of burgeoning Chinese capitalism.
For more information on Asia Entertainment & Resources Ltd., please visit the company’s investor relations website at: www.ir.aerlf.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The growing wealth, income gap, and relaxed monetary policies of modern China are priming the pump for explosive growth of the Casino/Gaming sector in Macau, and AERL is ideally positioned to profit from this growth. Investors are taking note of the potential AERL has as a leading promoter of VIP gaming, with solid ties to key locations in Macao’s hottest venues, like the Galaxy Star World Casino in downtown Macau (12 tables), in addition to the Venetian Macao-Resort-Hotel (5 tables) and Galaxy Cotai (12 tables), both on the famous Cotai Strip.
The Cotai Strip is like the Las Vegas Strip and is the epicenter of tourism and gaming activity in Macau. A main reason for the company’s success has been to know where the action is and how to secure marketing/agreements. With 20-year veteran gaming industry management at the helm, AERL has been able to amass an impressive portfolio of over 1,600 agents/collaborators across Asia, crystallizing renewable agreements, yet achieving a very flexible, extensible framework for the business model.
Huge leeway to move to and add new casino locations, combined with a solid performance record, is generating substantial buzz for AERL. Top investment banking, securities, and investment management firm Maxim Group recently initiated coverage on AERL with a Buy rating and $12 price target, joining the list of other current Buy rating analysts at Janney Montgomery Scott, Sterne Agee, and Stifel Nicolaus.
A closer look at the annual audit and financial filings for fiscal 2011 confirm this solid outlook, with AERL reporting a 97% increase in revenues for the year over 2010 figures, with the two primary factors being a 91% jump in rolling chip turnover, and a 99% increase in adjusted net income (non-GAAP). Guidance offered indicates rolling chip turnover of $24.96B and adjusted net income (non-GAAP) in the $88-95M neighborhood for 2012.
That’s a very nice neighborhood to be in and the markets have taken note of the cherry fundamentals and obvious underlying dynamics, eyeing AERL as a perfect way to catch some of the heat from China’s overflowing economic cauldron.
The AERL Board approved a $0.10 per share semi-annual dividend after six-month financials were reported recently, subsequently also approving a 20% raise to $0.12, beginning with the first six-month dividend for 2012. Naturally, as this total dividend is some 15% of EBITDA, increased cash flows year-over-year will drive the figure higher, a likely possibility given the nature of the operations and AERL’s performance vectors.
Asia Entertainment & Resources is generating serious profitability and offers the kind of real discount profile that has investors buzzing (2.8x for 2012 P/E ratio). Maxim Group’s endorsement pegs the fundamentals as having a great future, and it is easy to see why the future of the gaming sector in Macau will continue to grow on the heels of burgeoning Chinese capitalism.
For more information on Asia Entertainment & Resources Ltd., please visit the company’s investor relations website at: www.ir.aerlf.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
SEFE, Inc. (SEFE) Set to Market Harmony III Commercial-Grade Atmospheric Power Collection and Generation System
SEFE has a remarkable proprietary system that utilizes a weather balloon-based platform and dynamic tethering system to send aloft a conductive line. The collector then harvests static electricity directly from the constantly recharged atmosphere, transforming it into current usable by generators and the existing power grid.
Working with consultants from FAA and the fabrication industry, SEFE has engineered a safe, fully FAA-compliant and affordable solution which can easily be deployed anywhere. The Harmony III is ideal for a variety of industrial, mining, military, and utility needs, promising to curb fossil fuel dependency while immediately contributing to carbon offset.
The components within the system’s architecture are very durable, and because the individual units are networked together remotely via secure encrypted wireless connection, it is very easy to maintain the entire grid of systems simultaneously or perform real-time diagnostics and status checks.
The most important component is the generator which is able to harvest and transform current into a usable format irrespective of the particular site demands. What makes this patented technology even more promising is its versatility and ability to meet future demands.
Just think of it, variations of the Harmony III, whose systems are backed by SEFE patents, could one day replace other forms of energy production; even renewables like wind, solar, and hydro-electric which bear major cost and logistical drawbacks compared to a network of SEFE units.
The global atmospheric electrical circuit is everywhere on earth and peak output occurs at varying altitudes. The SEFE unit is designed to dynamically adjust and find the “sweet spot” for maximum yield and unlike alternative energy is vastly more simple to deploy and connect.
The Harmony III might seem too good to be true but recent testing continues to produce data that not only is wattage available, even at low altitudes, but that the amount available increases sharply with altitude.
Output from the SEFE units is calculated as 1.01B kWh/year, enough to power 140 homes day and night, forever.
The impact of this technology is staggering and the implications should be readily apparent.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Working with consultants from FAA and the fabrication industry, SEFE has engineered a safe, fully FAA-compliant and affordable solution which can easily be deployed anywhere. The Harmony III is ideal for a variety of industrial, mining, military, and utility needs, promising to curb fossil fuel dependency while immediately contributing to carbon offset.
The components within the system’s architecture are very durable, and because the individual units are networked together remotely via secure encrypted wireless connection, it is very easy to maintain the entire grid of systems simultaneously or perform real-time diagnostics and status checks.
The most important component is the generator which is able to harvest and transform current into a usable format irrespective of the particular site demands. What makes this patented technology even more promising is its versatility and ability to meet future demands.
Just think of it, variations of the Harmony III, whose systems are backed by SEFE patents, could one day replace other forms of energy production; even renewables like wind, solar, and hydro-electric which bear major cost and logistical drawbacks compared to a network of SEFE units.
The global atmospheric electrical circuit is everywhere on earth and peak output occurs at varying altitudes. The SEFE unit is designed to dynamically adjust and find the “sweet spot” for maximum yield and unlike alternative energy is vastly more simple to deploy and connect.
The Harmony III might seem too good to be true but recent testing continues to produce data that not only is wattage available, even at low altitudes, but that the amount available increases sharply with altitude.
Output from the SEFE units is calculated as 1.01B kWh/year, enough to power 140 homes day and night, forever.
The impact of this technology is staggering and the implications should be readily apparent.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
VolitionRX Ltd. (VNRX) to Advance Blood-Based Diagnostics for Cancer
VolitonRX, a life sciences company focused on the development of diagnostic blood tests, is developing its Nucleosomics™ technology to measure and identify the signatures of nucleosomes (a protein component of a chromosome containing a short length of DNA) that are released into the blood as cells die. The company believes its pioneering technology will help detect early stage diseases that are characterized by high cell turnover, such as cancer.
When a cell dies, individual nucleosomes are released into the blood to be recycled. It is well-known that high levels of nucleosomes are released into the blood stream as a result of the cell death associated with certain diseases and that the structure of nucleosomes is altered in the chromosomes of cancer cells. VolitonRX’s technology evaluates the amount and types of nucleosomes present in the blood to provide accurate diagnosis.
VolitionRX is currently in the process of developing a number of Nucleosomics™ tests for different types of nucleosomes and has conducted small pilot studies to investigate whether these nucleosomes are present in the blood of cancer patients and whether cancer nucleosomes are different to nucleosomes from healthy cells. Clearly, the chances of surviving cancer are greatly improved by early detection and diagnosis.
VolitionRX’s Chief Scientific Officer, Jake Micallef, advised that preliminary studies of VolitionRX’s Nucleosomics technology have provided positive data, spurring further development and progression to large-scale clinical studies to support its revolutionary diagnostic blood tests.
“Early stage results from our laboratory have exceeded our expectations, and we hope to see equally positive results in larger scale retrospective clinical studies and prospective clinical studies currently in the pipeline,” he said.
VolitionRX is now focused on validating the results provided by these preliminary studies through large scale clinical studies to ensure development of a blood-based diagnostic for cancer is advanced as quickly as possible. More information on the company and its cutting-edge technology can be found at the following website: www.volitionrx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
When a cell dies, individual nucleosomes are released into the blood to be recycled. It is well-known that high levels of nucleosomes are released into the blood stream as a result of the cell death associated with certain diseases and that the structure of nucleosomes is altered in the chromosomes of cancer cells. VolitonRX’s technology evaluates the amount and types of nucleosomes present in the blood to provide accurate diagnosis.
VolitionRX is currently in the process of developing a number of Nucleosomics™ tests for different types of nucleosomes and has conducted small pilot studies to investigate whether these nucleosomes are present in the blood of cancer patients and whether cancer nucleosomes are different to nucleosomes from healthy cells. Clearly, the chances of surviving cancer are greatly improved by early detection and diagnosis.
VolitionRX’s Chief Scientific Officer, Jake Micallef, advised that preliminary studies of VolitionRX’s Nucleosomics technology have provided positive data, spurring further development and progression to large-scale clinical studies to support its revolutionary diagnostic blood tests.
“Early stage results from our laboratory have exceeded our expectations, and we hope to see equally positive results in larger scale retrospective clinical studies and prospective clinical studies currently in the pipeline,” he said.
VolitionRX is now focused on validating the results provided by these preliminary studies through large scale clinical studies to ensure development of a blood-based diagnostic for cancer is advanced as quickly as possible. More information on the company and its cutting-edge technology can be found at the following website: www.volitionrx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Ever-Glory International Group, Inc. (EVK) Reports Fiscal Year 2011 Financial Results and 2012 Guidance
Ever-Glory International Group, a leading apparel supply chain manager and retailer in China, today reported its financial results for its fiscal year ended December 31, 2011, reflecting strong sales and expansion initiatives.
“We’re very pleased with the significant progress we made in 2011, as sales in both our retail and wholesale segments continued to increase,” Edward Yihua Kang, chairman of the board and CEO of Ever-Glory stated in the press release. “We are especially encouraged by achieving the objectives of LA GO GO store expansion. As of December 31, 2011, we had 467 LA GO GO stores in China; we surpassed our goal of opening an additional 80 to 100 new stores in 2011! We had 293 stores at the end of 2010.”
For the fiscal year ended December 31, 2011, net sales increased 60.9 percent to $215.8 million from $134.1 million reported in 2010.
Total gross profit for 2011 increased 70.3 percent to $44.5 million from $26.2 million reported in 2010. Gross margin increased to 20.6 percent in 2011, compared to 19.5 percent in 2010.
Full-year 2011 income from operations increased 82.2 percent to $12.1 million from $6.6 million in 2010.
As of December 31, 2011, the Ever-Glory had approximately $8.8 million of cash and cash equivalents, compared to approximately $3.7 million as of December 31, 2010; working capital of approximately $34.7 million as of December 31, 2011; and outstanding bank loans of approximately $29.2 million as of December 31, 2011.
For the first quarter of 2012, Every-Glory forecast total net sales between $50 million and $60 million and net income between $1.8 million and $2.2 million. For full-year 2012, the company said it anticipates total net sales between $225 million and $260 million and net income between $9.5 million and $12 million.
“For 2012, we see our basic strategies of retail business as unchanged, we will continue to develop LA GO GO through perfecting design styles, improving store management efficiency and opening more stores in desired locations,” Kang stated. “We are confident that, continuing to pursue these measures, we can enhance same-store sales, expand LA GO GO’s market penetration and increase its brand position in China.”
For more information visit www.everglorygroup.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
“We’re very pleased with the significant progress we made in 2011, as sales in both our retail and wholesale segments continued to increase,” Edward Yihua Kang, chairman of the board and CEO of Ever-Glory stated in the press release. “We are especially encouraged by achieving the objectives of LA GO GO store expansion. As of December 31, 2011, we had 467 LA GO GO stores in China; we surpassed our goal of opening an additional 80 to 100 new stores in 2011! We had 293 stores at the end of 2010.”
For the fiscal year ended December 31, 2011, net sales increased 60.9 percent to $215.8 million from $134.1 million reported in 2010.
Total gross profit for 2011 increased 70.3 percent to $44.5 million from $26.2 million reported in 2010. Gross margin increased to 20.6 percent in 2011, compared to 19.5 percent in 2010.
Full-year 2011 income from operations increased 82.2 percent to $12.1 million from $6.6 million in 2010.
As of December 31, 2011, the Ever-Glory had approximately $8.8 million of cash and cash equivalents, compared to approximately $3.7 million as of December 31, 2010; working capital of approximately $34.7 million as of December 31, 2011; and outstanding bank loans of approximately $29.2 million as of December 31, 2011.
For the first quarter of 2012, Every-Glory forecast total net sales between $50 million and $60 million and net income between $1.8 million and $2.2 million. For full-year 2012, the company said it anticipates total net sales between $225 million and $260 million and net income between $9.5 million and $12 million.
“For 2012, we see our basic strategies of retail business as unchanged, we will continue to develop LA GO GO through perfecting design styles, improving store management efficiency and opening more stores in desired locations,” Kang stated. “We are confident that, continuing to pursue these measures, we can enhance same-store sales, expand LA GO GO’s market penetration and increase its brand position in China.”
For more information visit www.everglorygroup.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Tuesday, March 27, 2012
Fortuna Silver Mines (FSM) Reports Updated Reserve and Resource Report
Fortuna Silver Mines released an updated mineral reserve and resources report on two of the company’s mines in South America. The properties produce gold, silver and other minerals.
Fortuna Silver Mines operates the Caylloma Mine located in Peru and reported that the mine contains 781,000 tons of proved and probable reserves located in various rock veins at the property. This was a 52% increase over the previous mineral reserves and resources report.
Fortuna Silver Mines said that contained silver in these veins increased to 9.4 million ounces, a 40% increase over last year. The company has additional proved and probable reserves in polymetallic veins at the Caylloma Mine.
Fortuna Silver Mines also operates the San Jose Mine located in Mexico and commenced production from here in September 2011. The company reported 3.6 million tons of proven and probable reserves at the San Jose Mine, including 23.6 million ounces of silver and 183,700 ounces of gold.
Fortuna Silver Mines is conducting additional exploration at the San Jose Mine in 2012 and expects to obtain approximately 15,000 meters of core samples at the property.
The updated resource and reserve estimates were supervised by E. Chapman and E. Vilela, two employees of the company that are considered Qualified Persons under the applicable regulations.
For more information on the company, go to www.fortunasilver.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Fortuna Silver Mines operates the Caylloma Mine located in Peru and reported that the mine contains 781,000 tons of proved and probable reserves located in various rock veins at the property. This was a 52% increase over the previous mineral reserves and resources report.
Fortuna Silver Mines said that contained silver in these veins increased to 9.4 million ounces, a 40% increase over last year. The company has additional proved and probable reserves in polymetallic veins at the Caylloma Mine.
Fortuna Silver Mines also operates the San Jose Mine located in Mexico and commenced production from here in September 2011. The company reported 3.6 million tons of proven and probable reserves at the San Jose Mine, including 23.6 million ounces of silver and 183,700 ounces of gold.
Fortuna Silver Mines is conducting additional exploration at the San Jose Mine in 2012 and expects to obtain approximately 15,000 meters of core samples at the property.
The updated resource and reserve estimates were supervised by E. Chapman and E. Vilela, two employees of the company that are considered Qualified Persons under the applicable regulations.
For more information on the company, go to www.fortunasilver.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Echelon Corp. (ELON) and Holley Metering to Form Joint Venture Smart Grid Solutions Company in China
Echelon Corporation and Holley Metering Limited announced today an agreement between the two companies to form a joint venture company in China. Zhejiang Echelon-Holley Technology Co. Ltd. will focus on developing and selling advanced smart metering products for China.
Headquartered in Hangzhou, China, the new company will develop advanced smart metering and related solutions to deliver performance, reliability, and expanded functionality to China’s emerging smart grid – answering the mandate to connect 300 million homes and businesses to the country’s smart grid over the next five years. The partnership will combine the expertise of Echelon’s Silicon Valley energy control networking center, which retains two decades of experience in power line control and smart grid communications hardware and software platforms, with Holley Metering’s expanse of metering solutions, affordable manufacturing competencies and vast customer relationships.
This joint venture is majority owned by Echelon; both companies will contribute cash and resources to the new company. The joint venture is anticipated to be operational by the third quarter of 2012.
Echelon Corporation is a world leader in energy control networking for smart grid, smart city, and smart building applications. The company’s platform is embedded in more than 100 million devices, 35 million homes, and 300,000 buildings. Echelon helps customers’ reduce their operational costs, enhance safety, grow revenues and prepare for the future.
For more information about the company, visit www.echelon.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Headquartered in Hangzhou, China, the new company will develop advanced smart metering and related solutions to deliver performance, reliability, and expanded functionality to China’s emerging smart grid – answering the mandate to connect 300 million homes and businesses to the country’s smart grid over the next five years. The partnership will combine the expertise of Echelon’s Silicon Valley energy control networking center, which retains two decades of experience in power line control and smart grid communications hardware and software platforms, with Holley Metering’s expanse of metering solutions, affordable manufacturing competencies and vast customer relationships.
This joint venture is majority owned by Echelon; both companies will contribute cash and resources to the new company. The joint venture is anticipated to be operational by the third quarter of 2012.
Echelon Corporation is a world leader in energy control networking for smart grid, smart city, and smart building applications. The company’s platform is embedded in more than 100 million devices, 35 million homes, and 300,000 buildings. Echelon helps customers’ reduce their operational costs, enhance safety, grow revenues and prepare for the future.
For more information about the company, visit www.echelon.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Uranium Energy Corp. (UEC) Positioned to Profit from Strong Future for Nuclear Energy Production Industry
Uranium Energy has quickly developed an impressive portfolio of acreage, permits, and processing infrastructure in Texas and is shaping up to be a dominant leader in domestic uranium production for a growing global market that continues to crave nuclear as a means of satisfying the burgeoning demand for electricity.
PM Harper was on an Asian tour recently, capped off by attending the Nuclear Security Summit in Seoul, where there is a strong future for Canadian output, with Saskatchewan being most notable as a source of high-grade North American uranium. This subject was discussed in a recent Business News Network interview of Vancouver-based Casey Research guru (which is renowned for their sector analysis), Marin Katusa, where UEC was noted as being one of a handful of select domestic companies well-positioned to make serious moves off the prevailing dynamics.
One year post Fukushima we see Germany attempting to scale back nuclear output, despite the obviously unrealistic goal of closing nuclear plants down by 2022. Pre-Fukushima U3O8 yellow cake was around $70 with the spot price not uncommonly hitting the $75-77 range, but now were around $50 and stagnant one year hence. However, Japan, Korea, China, and even Russia have not only planned but already started production of new, large nuclear facilities.
This is a crucial phase for snap-back in U3O8 though as we are within 12 months of the US-Russian HEU (highly enriched uranium via large scale dismantling of former Soviet warheads) deal expiring, meaning momentum for the commodity should really start to pick up and that the entire sector looks charged with an energy world demanding more and more kilowatt hours.
With large Russian companies heavily investing in Africa and elsewhere, the Putin-led move to secure raw materials infrastructure is evident in the uranium sector, leading to a clear indicator for the global nuclear market that nuclear isn’t going anywhere. In fact the profile seems rather clear that not only is nuclear here to stay, but governments and industry across the globe will be looking to create modern infrastructure to avoid the pitfalls of TEPCO and Fukushima, with better equipment and facilities.
With Putin moving to secure stable supply lines via an off take agreement with China, or other, more permanent feed solutions, in order to crystallize long-term nuclear output for the Russian market, it looks like the future of demand for uranium in the U.S. (we import upwards of 92-95% of our uranium) is clear. It is increasingly clear that Russia, China, and India are holding many of the cards required to execute a competent nuclear strategy, with Russia being in an enviable, almost monopoly position as ongoing deals emerge.
That’s why a domestic ISR operation like UEC is so important and why investors are looking very closely at this rapidly growing uranium miner. The efficient, environmentally friendly ISR method (in-situ recovery is basically injected-solution mining, use pump-in and recovery/production wells across a grid on the acreage) of resource recovery employed by the company is just an excellent bonus. The future of US energy security depends on nuclear and on domestic uranium producers like UEC.
So the era of cheap HEU-derived yellow cake is drawing to a close and the spot price hasn’t moved upwards really since Fukushima, but the fundamentals are like an elephant in the room. That’s okay, UEC has an elephant gun: cheap, efficient, low-environmental impact, yet high-volume ISR of high-quality domestic uranium resources, along with a shrewdly located processing facility to handle production of the final product.
We lack the infrastructure to down-blend our own nuclear warheads like the Russians have done for the HEU program. We would have to send our warheads to Russia for them to down-blend, then ship back – this is a critical energy security vulnerability gap and few companies other than UEC possess the competencies, infrastructure, and capability to deliver domestically-sourced solutions. Katsua emphasized the global playing field and overall market vector, with 64 nuclear plants currently under construction, 150 planned, and 330 proposed as sufficient evidence to demand U.S. action addressing the problem of where exactly we intend to get the uranium we need to power 20% of our own electrical generation architecture.
Low cost producers like UEC, of which there are few, are in a prime position to experience strong growth as the underlying market dynamics progress in an energy-hungry, growing world, with the next twelve months being an obvious window of major activity as elements within the market prepare for the HEU-related falloff of inputs.
Katsua put a spotlight on UEC as a cherry pick for investors looking to play the uranium sector “split”. Texas location, permitting in-hand (or looking solid), extremely low-cost production method with dollars spent per quantity extracted among the lowest in the entire sector thanks in large part to ISRs efficiency and what UEC has done to revolutionize the technology, are all salient points for investors to examine closely.
The operational footprint UEC has amassed between the company’s four main sites in the heart of the South Texas Uranium Belt, where some of the highest-grade domestic uranium available exists, is impressive, and the company is constantly moving to secure additional acreage around its centrally-located Hobson Processing facility:
• Hobson Processing Plant
Operating – The Hobson ISR Processing Plant is central to Texas Operations and is designed to process uranium-loaded resins to final U3O8 product.
• Palangana Uranium Project
Producing – Satellite Project with a 2.2M lb Resource (NI 43-101).
• Goliad Uranium Project
Final Stage of Permitting – Satellite Project Amenable to ISR with a 6.9M lb Resource.
• Salvo Uranium Project
Phase One Drilling – Planned as a third Satellite Project with a 2.8M lb Resource.
• Nichols Uranium Project
Phase One Drilling – Planned as a fourth Satellite Project with a 1.31M lb Resource.
Famed mineral hound Mickey Fulp, The Mercenary Geologist, known for his sector analysis and newsletters said of UEC last year that it was one of the few companies he was bullish about. This is high praise from Mickey, who indicated having continued to buy UEC post-Fukushima.
For more information on Uranium Energy Corp., please visit the company’s website at: UraniumEnergy.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
PM Harper was on an Asian tour recently, capped off by attending the Nuclear Security Summit in Seoul, where there is a strong future for Canadian output, with Saskatchewan being most notable as a source of high-grade North American uranium. This subject was discussed in a recent Business News Network interview of Vancouver-based Casey Research guru (which is renowned for their sector analysis), Marin Katusa, where UEC was noted as being one of a handful of select domestic companies well-positioned to make serious moves off the prevailing dynamics.
One year post Fukushima we see Germany attempting to scale back nuclear output, despite the obviously unrealistic goal of closing nuclear plants down by 2022. Pre-Fukushima U3O8 yellow cake was around $70 with the spot price not uncommonly hitting the $75-77 range, but now were around $50 and stagnant one year hence. However, Japan, Korea, China, and even Russia have not only planned but already started production of new, large nuclear facilities.
This is a crucial phase for snap-back in U3O8 though as we are within 12 months of the US-Russian HEU (highly enriched uranium via large scale dismantling of former Soviet warheads) deal expiring, meaning momentum for the commodity should really start to pick up and that the entire sector looks charged with an energy world demanding more and more kilowatt hours.
With large Russian companies heavily investing in Africa and elsewhere, the Putin-led move to secure raw materials infrastructure is evident in the uranium sector, leading to a clear indicator for the global nuclear market that nuclear isn’t going anywhere. In fact the profile seems rather clear that not only is nuclear here to stay, but governments and industry across the globe will be looking to create modern infrastructure to avoid the pitfalls of TEPCO and Fukushima, with better equipment and facilities.
With Putin moving to secure stable supply lines via an off take agreement with China, or other, more permanent feed solutions, in order to crystallize long-term nuclear output for the Russian market, it looks like the future of demand for uranium in the U.S. (we import upwards of 92-95% of our uranium) is clear. It is increasingly clear that Russia, China, and India are holding many of the cards required to execute a competent nuclear strategy, with Russia being in an enviable, almost monopoly position as ongoing deals emerge.
That’s why a domestic ISR operation like UEC is so important and why investors are looking very closely at this rapidly growing uranium miner. The efficient, environmentally friendly ISR method (in-situ recovery is basically injected-solution mining, use pump-in and recovery/production wells across a grid on the acreage) of resource recovery employed by the company is just an excellent bonus. The future of US energy security depends on nuclear and on domestic uranium producers like UEC.
So the era of cheap HEU-derived yellow cake is drawing to a close and the spot price hasn’t moved upwards really since Fukushima, but the fundamentals are like an elephant in the room. That’s okay, UEC has an elephant gun: cheap, efficient, low-environmental impact, yet high-volume ISR of high-quality domestic uranium resources, along with a shrewdly located processing facility to handle production of the final product.
We lack the infrastructure to down-blend our own nuclear warheads like the Russians have done for the HEU program. We would have to send our warheads to Russia for them to down-blend, then ship back – this is a critical energy security vulnerability gap and few companies other than UEC possess the competencies, infrastructure, and capability to deliver domestically-sourced solutions. Katsua emphasized the global playing field and overall market vector, with 64 nuclear plants currently under construction, 150 planned, and 330 proposed as sufficient evidence to demand U.S. action addressing the problem of where exactly we intend to get the uranium we need to power 20% of our own electrical generation architecture.
Low cost producers like UEC, of which there are few, are in a prime position to experience strong growth as the underlying market dynamics progress in an energy-hungry, growing world, with the next twelve months being an obvious window of major activity as elements within the market prepare for the HEU-related falloff of inputs.
Katsua put a spotlight on UEC as a cherry pick for investors looking to play the uranium sector “split”. Texas location, permitting in-hand (or looking solid), extremely low-cost production method with dollars spent per quantity extracted among the lowest in the entire sector thanks in large part to ISRs efficiency and what UEC has done to revolutionize the technology, are all salient points for investors to examine closely.
The operational footprint UEC has amassed between the company’s four main sites in the heart of the South Texas Uranium Belt, where some of the highest-grade domestic uranium available exists, is impressive, and the company is constantly moving to secure additional acreage around its centrally-located Hobson Processing facility:
• Hobson Processing Plant
Operating – The Hobson ISR Processing Plant is central to Texas Operations and is designed to process uranium-loaded resins to final U3O8 product.
• Palangana Uranium Project
Producing – Satellite Project with a 2.2M lb Resource (NI 43-101).
• Goliad Uranium Project
Final Stage of Permitting – Satellite Project Amenable to ISR with a 6.9M lb Resource.
• Salvo Uranium Project
Phase One Drilling – Planned as a third Satellite Project with a 2.8M lb Resource.
• Nichols Uranium Project
Phase One Drilling – Planned as a fourth Satellite Project with a 1.31M lb Resource.
Famed mineral hound Mickey Fulp, The Mercenary Geologist, known for his sector analysis and newsletters said of UEC last year that it was one of the few companies he was bullish about. This is high praise from Mickey, who indicated having continued to buy UEC post-Fukushima.
For more information on Uranium Energy Corp., please visit the company’s website at: UraniumEnergy.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
GlobalWise Investments, Inc. (GWIV) Forges Channel Sales Partnership with National Business-to-Business Reseller of IT Hardware and Software
GlobalWise Investments and its wholly owned subsidiary Intellinetics, a leading-edge technology company focused on the design, implementation, and management of cloud-based Enterprise Content Management (“ECM”) systems, announced the execution of a new Channel Sales Partnership with B2B Computer Products, LLC. With a foundation of deep IT industry experience, B2B Computer Products LLC was identified by Inc. magazine as one of the fastest growing businesses of its type in the U.S. in 2009 and 2010.
B2B Computer Products, LLC is a national business-to-business value-added reseller and service provider of computer hardware and software with over 35 distribution centers throughout the U.S. They are a client-focused technology provider with proven experience in design, product recommendation, and implementation of complex multi-vendor IT solutions. Through the newly announced partnership, B2B Computer will be able to add the cloud-based Intellivue™ ECM software to its vast array of service offerings and better serve its roster of over 24,000 clients.
“B2B Computer is thrilled to add the Intellivue™ suite of software services to our list of business solutions,” stated Rob Ince, Business Development Manager for B2B Computer. “Enterprise Content Management offers a natural extension to the server and storage solutions B2B Computer provides its customers. As a hosted service, Intellivue™ can also complement our Managed Print Service offering by using Multi-Function Device printers for scanning. The shared device approach combined with the efficiency gains inherent in routing documents electronically with the Intellivue™ workflow capability will equate to a quick ROI (Return on Investment) for our clients.”
“B2B Computer is a trusted name in the software and hardware business,” commented William. J. “BJ” Santiago, CEO of GlobalWise. “They have a proven, solid track record with a large client base and can instantly go-to-market with our software offering as a natural extension of what they do every day. Having an affordable, enterprise class software solution to manage unstructured content and documents will be a huge benefit to B2B Computer’s clients. We are actively pursuing multiple new client sales opportunities that have already resulted from this partnership. Each of these opportunities average $40,000 per engagement. We look forward to growing our relationship and supporting B2B Computer in their daily business to acquire new ECM clients.”
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
B2B Computer Products, LLC is a national business-to-business value-added reseller and service provider of computer hardware and software with over 35 distribution centers throughout the U.S. They are a client-focused technology provider with proven experience in design, product recommendation, and implementation of complex multi-vendor IT solutions. Through the newly announced partnership, B2B Computer will be able to add the cloud-based Intellivue™ ECM software to its vast array of service offerings and better serve its roster of over 24,000 clients.
“B2B Computer is thrilled to add the Intellivue™ suite of software services to our list of business solutions,” stated Rob Ince, Business Development Manager for B2B Computer. “Enterprise Content Management offers a natural extension to the server and storage solutions B2B Computer provides its customers. As a hosted service, Intellivue™ can also complement our Managed Print Service offering by using Multi-Function Device printers for scanning. The shared device approach combined with the efficiency gains inherent in routing documents electronically with the Intellivue™ workflow capability will equate to a quick ROI (Return on Investment) for our clients.”
“B2B Computer is a trusted name in the software and hardware business,” commented William. J. “BJ” Santiago, CEO of GlobalWise. “They have a proven, solid track record with a large client base and can instantly go-to-market with our software offering as a natural extension of what they do every day. Having an affordable, enterprise class software solution to manage unstructured content and documents will be a huge benefit to B2B Computer’s clients. We are actively pursuing multiple new client sales opportunities that have already resulted from this partnership. Each of these opportunities average $40,000 per engagement. We look forward to growing our relationship and supporting B2B Computer in their daily business to acquire new ECM clients.”
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Glowpoint, Inc. (GLOW) Announces Expanded Cloud B2B Exchange Services for Increased Intercompany Visual Communication
Yesterday, Glowpoint announced expanded B2B video exchange services that will enable business customers to easily and securely collaborate with more partners via visual communication from the cloud.
The OpenVideo cloud’s expanded B2B visual communication capabilities include seamless access on all leading multi-vendor global B2B exchanges, easy online scheduling for B2B calls, and B2B video call support for Cisco CTS systems. Glowpoint’s OpenVideo cloud platform supports and delivers all these new features and capabilities, including a new Multi-Protocol Video Trunk (MPVT) that provides a single connection to the cloud and expands access to customers and partners on other B2B exchanges.
The MPVT supports inbound and outbound video system calling over a single transport link, and it also enables businesses to register their entire private networks to the OpenVideo cloud rather than registering potentially hundreds of endpoints individually. This gives IT managers a more efficient method for providing B2B video calling capabilities, including ad-hoc point-to-point calling using simple DIDs and URIs.
Through its ongoing partnership with Tata Communications, Glowpoint will now offer direct B2B calling from the OpenVideo cloud on the Global Meeting Exchange (GMX), which will allow Glowpoint and Tata to give customers access to more partners for B2B video calling – eliminating the need for multiple connections to different B2B exchanges. The GMX additionally provides access to exchanges that are operated by other service providers.
Glowpoint is a global leader in providing cloud-managed video services that simplify the delivery of high-quality videoconferencing and telepresence service between any technology, network, and business. Glowpoint’s OpenVideo cloud architecture allows organizations to easily implement business-class video, instantly scale, and openly and securely collaborate across technology boundaries. Glowpoint is an active member of the Open Visual Communications Consortium (OVCC) and will be among the initial operators offering OVCC compliant B2B service in fall 2012.
For more information, visit the company’s Web site at www.glowpoint.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The OpenVideo cloud’s expanded B2B visual communication capabilities include seamless access on all leading multi-vendor global B2B exchanges, easy online scheduling for B2B calls, and B2B video call support for Cisco CTS systems. Glowpoint’s OpenVideo cloud platform supports and delivers all these new features and capabilities, including a new Multi-Protocol Video Trunk (MPVT) that provides a single connection to the cloud and expands access to customers and partners on other B2B exchanges.
The MPVT supports inbound and outbound video system calling over a single transport link, and it also enables businesses to register their entire private networks to the OpenVideo cloud rather than registering potentially hundreds of endpoints individually. This gives IT managers a more efficient method for providing B2B video calling capabilities, including ad-hoc point-to-point calling using simple DIDs and URIs.
Through its ongoing partnership with Tata Communications, Glowpoint will now offer direct B2B calling from the OpenVideo cloud on the Global Meeting Exchange (GMX), which will allow Glowpoint and Tata to give customers access to more partners for B2B video calling – eliminating the need for multiple connections to different B2B exchanges. The GMX additionally provides access to exchanges that are operated by other service providers.
Glowpoint is a global leader in providing cloud-managed video services that simplify the delivery of high-quality videoconferencing and telepresence service between any technology, network, and business. Glowpoint’s OpenVideo cloud architecture allows organizations to easily implement business-class video, instantly scale, and openly and securely collaborate across technology boundaries. Glowpoint is an active member of the Open Visual Communications Consortium (OVCC) and will be among the initial operators offering OVCC compliant B2B service in fall 2012.
For more information, visit the company’s Web site at www.glowpoint.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Delcath Systems, Inc. (DCTH) Bolsters Global Marketing Team with Strategic Pharma Oncology Hire
Delcath Systems announced the appointment of Jennifer Simpson, Ph.D., M.S.N., C.R.N.P., to the position of Executive Vice President, Global Marketing. Ms. Simpson will use her extensive pharmaceutical and oncology marketing background to lead Delcath’s global product marketing, brand management and reimbursement programs in the European Union, United States, and other key markets. In line with Ms. Simpson’s appointment, Agustin Gago, Delcath’s Executive Vice President for Global Sales & Marketing since 2009, will assume the new role of Executive Vice President, Global Sales. Ms. Simpson and Mr. Gago will both report to Eamonn P. Hobbs, President and CEO of Delcath. Both appointments were effective as of March 23, 2012.
Ms. Simpson has a wealth of experience in global product development in the oncology sector. Before bringing her talents and knowledge to Delcath, Ms. Simpson served as the Vice President, Global Marketing, Oncology Brand Lead at ImClone Systems, Inc. (a wholly-owned subsidiary of Eli Lilly and Company). As Vice President, she successfully handled all product commercialization activities and launch preparation for one of the late stage assets. During her time at ImClone, Ms. Simpson also excelled in various positions of increasing responsibility including Vice President, Product Champion and the Associate Vice President, Product Champion.
In addition to her successes at ImClone, Ms. Simpson held multiple leadership positions at Ortho Biotech (now Janssen Biotech), a Pennsylvania-based biotech company that focuses on innovative solutions in immunology, oncology, and nephrology. Before her stint at Ortho Biotech, Ms. Simpson acquired over 10 years of experience as an oncology-nurse practitioner and educator.
“The appointment of Jennifer Simpson adds significant oncology expertise and leadership to our marketing team,” said Mr. Hobbs, President and CEO of Delcath. “Over the last year, we’ve made a concerted effort to build our talent base in order to drive the launch of our CHEMOSAT system. Jennifer’s extensive experience in cancer treatment as a nurse, educator, marketer and strategic planner, combined with an intimate knowledge of the commercialization process makes her an ideal fit. We’re confident that she will help us realize the full global market potential of CHEMOSAT.”
“The planned transition of Mr. Gago to the position of Executive Vice President, Global Sales will allow him to fully devote his energies to the execution of our global commercial sales strategy. Through Mr. Gago’s sales leadership, we are successfully implementing our launch plan for CHEMOSAT in the EU, and will continue to expand the opportunity for CHEMOSAT in new markets around the world.”
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Ms. Simpson has a wealth of experience in global product development in the oncology sector. Before bringing her talents and knowledge to Delcath, Ms. Simpson served as the Vice President, Global Marketing, Oncology Brand Lead at ImClone Systems, Inc. (a wholly-owned subsidiary of Eli Lilly and Company). As Vice President, she successfully handled all product commercialization activities and launch preparation for one of the late stage assets. During her time at ImClone, Ms. Simpson also excelled in various positions of increasing responsibility including Vice President, Product Champion and the Associate Vice President, Product Champion.
In addition to her successes at ImClone, Ms. Simpson held multiple leadership positions at Ortho Biotech (now Janssen Biotech), a Pennsylvania-based biotech company that focuses on innovative solutions in immunology, oncology, and nephrology. Before her stint at Ortho Biotech, Ms. Simpson acquired over 10 years of experience as an oncology-nurse practitioner and educator.
“The appointment of Jennifer Simpson adds significant oncology expertise and leadership to our marketing team,” said Mr. Hobbs, President and CEO of Delcath. “Over the last year, we’ve made a concerted effort to build our talent base in order to drive the launch of our CHEMOSAT system. Jennifer’s extensive experience in cancer treatment as a nurse, educator, marketer and strategic planner, combined with an intimate knowledge of the commercialization process makes her an ideal fit. We’re confident that she will help us realize the full global market potential of CHEMOSAT.”
“The planned transition of Mr. Gago to the position of Executive Vice President, Global Sales will allow him to fully devote his energies to the execution of our global commercial sales strategy. Through Mr. Gago’s sales leadership, we are successfully implementing our launch plan for CHEMOSAT in the EU, and will continue to expand the opportunity for CHEMOSAT in new markets around the world.”
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Overland Storage, Inc. (OVRL) Hardware Product Recognized at 2012 Network Computing Awards
Global provider of data management and protection solutions, Overland Storage, announced that its SnapServer DX Series™ was named the ‘Hardware Product of the Year’ at the 2012 Network Computing Awards. The series also took the honor as runner up in the ‘Data Centre Product of the Year’ category. The awards were presented at a ceremony on 22nd March at Hotel Russell, London.
Launched in October 2011, the SnapServer DX Series is the ideal solution for modern business applications from virtualized server, Microsoft Exchange, SharePoint, and SQL environments to digital imaging, web services, storage consolidation, and backup.
SnapServer DX offers a unified NAS and iSCSI SAN device that leverages the company’s DynamicRaid™ technology to completely eliminate the need to provision storage capacity. The SnapServer DX Series enables storage environments to effortlessly scale without downtime while ensuring maximum data protection.
Jeremy Zuber, product marketing manager, SnapServer® division at Overland Storage, remarked, “The SnapServer DX Series was built to have the best features and price of any NAS solution in its class, to enable businesses of all sizes to take advantage of its power, flexibility and ease of us. This award recognises our achievement in creating an ideal solution that offers effortless data management and protection to modern businesses.”
The Network Computing Awards are hosted by Network Computing Magazine in the UK. Now in its fifth year, the awards recognize the hardware, software, and services which have most impressed the publication’s readers.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Launched in October 2011, the SnapServer DX Series is the ideal solution for modern business applications from virtualized server, Microsoft Exchange, SharePoint, and SQL environments to digital imaging, web services, storage consolidation, and backup.
SnapServer DX offers a unified NAS and iSCSI SAN device that leverages the company’s DynamicRaid™ technology to completely eliminate the need to provision storage capacity. The SnapServer DX Series enables storage environments to effortlessly scale without downtime while ensuring maximum data protection.
Jeremy Zuber, product marketing manager, SnapServer® division at Overland Storage, remarked, “The SnapServer DX Series was built to have the best features and price of any NAS solution in its class, to enable businesses of all sizes to take advantage of its power, flexibility and ease of us. This award recognises our achievement in creating an ideal solution that offers effortless data management and protection to modern businesses.”
The Network Computing Awards are hosted by Network Computing Magazine in the UK. Now in its fifth year, the awards recognize the hardware, software, and services which have most impressed the publication’s readers.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Taser International, Inc. (TASR) Receives Two Significant Orders
Taser International, Inc. is the manufacturer of the world famous taser. It is a global provider of safety technologies that protect lives, help prevent conflicts, and resolve disputes. The company’s products are used in 107 countries around the globe by more than 16,700 public safety agencies.
The company announced today that it has received two significant orders for its new Taser X2 electronic control device (ECD). The first order came from the Michigan Department of Corrections for 242 of the devices with 242 Taser Cam HD recorders, 3,783 Taser cartridges, and various related accessories. The second order received came from the Fort Worth Texas Police Department for 200 Taser X2 ECDs with extended warranties, 1,385 Smart Cartridges, and accessories. These orders are expected to ship in the first quarter of 2012.
This successful new product – the Taser X2 – was launched in 2011 as the company’s next generation electronic control device. It provides a second shot capability, charged metering for improved safety, Trilogy logs with detailed firing and electrical pulse information, automatic shut off ability, compatibility with Taser Cam HD high definition color video camera system, and free data upload access to Taser’s Evidence.com secure, cloud-based data storage and management solution service.
For additional information about Taser International and its various products, please visit the company’s website at www.taser.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The company announced today that it has received two significant orders for its new Taser X2 electronic control device (ECD). The first order came from the Michigan Department of Corrections for 242 of the devices with 242 Taser Cam HD recorders, 3,783 Taser cartridges, and various related accessories. The second order received came from the Fort Worth Texas Police Department for 200 Taser X2 ECDs with extended warranties, 1,385 Smart Cartridges, and accessories. These orders are expected to ship in the first quarter of 2012.
This successful new product – the Taser X2 – was launched in 2011 as the company’s next generation electronic control device. It provides a second shot capability, charged metering for improved safety, Trilogy logs with detailed firing and electrical pulse information, automatic shut off ability, compatibility with Taser Cam HD high definition color video camera system, and free data upload access to Taser’s Evidence.com secure, cloud-based data storage and management solution service.
For additional information about Taser International and its various products, please visit the company’s website at www.taser.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
UTStarcom Holdings Corp. (UTSI) IPTV Platform Receives Influential Award from Chinese Ministry of Science and Technology at Key Cable Industry Trade Show in Beijing
UTStarcom, which has developed a broad spectrum portfolio of IPTV solutions ranging from the mundane to advanced NGN (next generation network) frameworks, reported reception today of a key Innovation Award from the Chinese Ministry of Science and Technology for their integrated IPTV broadcasting control platform, which was designed around China’s network convergence goals set forth in the Triple Network Convergence Policy.
China’s Triple Network Convergence Policy seeks to fuse together cable, voice, and Internet networks. The UTSI platform was awarded during a top Chinese cable operator trade show, the 20th Annual China Content Broadcasting Network (CCBN) exhibition in Beijing, marking a serious win for the company that has also generated significant collateral buzz. Held at the prestigious China International Exhibition Center in the heart of the PRC’s capital, the CCBN was an ideal showcase for UTSI’s superb technology offerings.
And what’s not to like? UTSI is buzz-worthy, with a portfolio that covers the entire range of requisite technology competencies required to spearhead precisely this kind of government-led initiative to transform China’s infoscape. With vast territory in interactive IP-based network solutions that stretches well beyond IPTV, iDTV, and Internet TV, to Broadband for cable and telecoms, NGN solutions like IP telephony for next-gen voice/data networks, optical transport networks, and customer premise concepts like set-top boxes, UTSI is a serious industry force to be reckoned with.
The UTSI, IPTV broadcasting control platform was designed to destroy the competition and claim the prize, with full support capability for content distribution functions across IPTV, iDTV, and Internet TV, handling multiple output vectors to just about any networkable device from TVs and PCs, to tablets, mobiles, and smartphones. An initial twelve trial cities from 2010 in the first-phase roll out saw the installation of six IPTV platforms in key markets (Beijing, Hubei, Hunan, Shandong, Shenzhen, and Sichuan), with UTSI also setting up systems in key ancillary markets like Tianjin and Hangzhou, thus carving out a massive slice of the Chinese cable pie.
The Innovation Award is a coveted prize among leaders in the Chinese cable industry as a whole and UTSI was chosen due to the powerful design concept execution evident in their IPTV broadcasting control platform. Razor-sharp, cutting-edge technologies and a winning service envelope sealed the deal for UTSI at this year’s CCBN, making it the fourth time the company has received the award, a real testament to the continued success of UTStarcom at innovating in the field.
President and CEO or UTSI, Jack Lu, hailed the Chinese Ministry of Science for this continued recognition of the company’s ability to execute with exemplary solutions, pledging to ride the Chinese convergence wave to serious growth and ROI for investors in and beyond 2012.
Lu emphasized the 42 trial city, phase-two roll out announced at the end of last year as being fundamental to opening up new market opportunities for the proven model/portfolio, vowing to maintain that focus on the cable market which has spelled such success for UTSI thus far. Higher margins and higher bookings from sales in 2011 have underlined the value of the cable area for the company and with such solutions being light up by the bright lights of key industry awards, handed out by the agencies pushing convergence, UTSI is a smart move that is showing real growth potential as they hammer out a clear migration path to cost-effective, end-to-end IP network solutions.
For more information on the reception of this influential award, or to learn more about UTStarcom Holdings Corp., please visit the company’s website at: www.UTStar.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
China’s Triple Network Convergence Policy seeks to fuse together cable, voice, and Internet networks. The UTSI platform was awarded during a top Chinese cable operator trade show, the 20th Annual China Content Broadcasting Network (CCBN) exhibition in Beijing, marking a serious win for the company that has also generated significant collateral buzz. Held at the prestigious China International Exhibition Center in the heart of the PRC’s capital, the CCBN was an ideal showcase for UTSI’s superb technology offerings.
And what’s not to like? UTSI is buzz-worthy, with a portfolio that covers the entire range of requisite technology competencies required to spearhead precisely this kind of government-led initiative to transform China’s infoscape. With vast territory in interactive IP-based network solutions that stretches well beyond IPTV, iDTV, and Internet TV, to Broadband for cable and telecoms, NGN solutions like IP telephony for next-gen voice/data networks, optical transport networks, and customer premise concepts like set-top boxes, UTSI is a serious industry force to be reckoned with.
The UTSI, IPTV broadcasting control platform was designed to destroy the competition and claim the prize, with full support capability for content distribution functions across IPTV, iDTV, and Internet TV, handling multiple output vectors to just about any networkable device from TVs and PCs, to tablets, mobiles, and smartphones. An initial twelve trial cities from 2010 in the first-phase roll out saw the installation of six IPTV platforms in key markets (Beijing, Hubei, Hunan, Shandong, Shenzhen, and Sichuan), with UTSI also setting up systems in key ancillary markets like Tianjin and Hangzhou, thus carving out a massive slice of the Chinese cable pie.
The Innovation Award is a coveted prize among leaders in the Chinese cable industry as a whole and UTSI was chosen due to the powerful design concept execution evident in their IPTV broadcasting control platform. Razor-sharp, cutting-edge technologies and a winning service envelope sealed the deal for UTSI at this year’s CCBN, making it the fourth time the company has received the award, a real testament to the continued success of UTStarcom at innovating in the field.
President and CEO or UTSI, Jack Lu, hailed the Chinese Ministry of Science for this continued recognition of the company’s ability to execute with exemplary solutions, pledging to ride the Chinese convergence wave to serious growth and ROI for investors in and beyond 2012.
Lu emphasized the 42 trial city, phase-two roll out announced at the end of last year as being fundamental to opening up new market opportunities for the proven model/portfolio, vowing to maintain that focus on the cable market which has spelled such success for UTSI thus far. Higher margins and higher bookings from sales in 2011 have underlined the value of the cable area for the company and with such solutions being light up by the bright lights of key industry awards, handed out by the agencies pushing convergence, UTSI is a smart move that is showing real growth potential as they hammer out a clear migration path to cost-effective, end-to-end IP network solutions.
For more information on the reception of this influential award, or to learn more about UTStarcom Holdings Corp., please visit the company’s website at: www.UTStar.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Subscribe to:
Posts (Atom)